POPULARITY
Categories
175 episodes with PCP
129 episodes with PCP
146 episodes with PCP
201 episodes with PCP
85 episodes with PCP
42 episodes with PCP
19 episodes with PCP
22 episodes with PCP
39 episodes with PCP
35 episodes with PCP
31 episodes with PCP
60 episodes with PCP
24 episodes with PCP
10 episodes with PCP
7 episodes with PCP
10 episodes with PCP
10 episodes with PCP
13 episodes with PCP
10 episodes with PCP
5 episodes with PCP
5 episodes with PCP
12 episodes with PCP
13 episodes with PCP
25 episodes with PCP
8 episodes with PCP
6 episodes with PCP
6 episodes with PCP
15 episodes with PCP
15 episodes with PCP
9 episodes with PCP
12 episodes with PCP
3 episodes with PCP
5 episodes with PCP
6 episodes with PCP
6 episodes with PCP
16 episodes with PCP
105 episodes with PCP
4 episodes with PCP
4 episodes with PCP
4 episodes with PCP
2 episodes with PCP
6 episodes with PCP
6 episodes with PCP
3 episodes with PCP
89 episodes with PCP
8 episodes with PCP
11 episodes with PCP
3 episodes with PCP
2 episodes with PCP
3 episodes with PCP
4 episodes with PCP
3 episodes with PCP
3 episodes with PCP
8 episodes with PCP
no inserted ads: www.patreon.com/dopeypodcastThis Week on a super classic episode of Dopey! Dave is visited by local Long Islander - Will P. AKA Hairy Tongue Will. Dave opens the show drinking Ryze mushroom coffee while talking about how cold his recording room is. He announces that Dopey will be releasing five episodes per week throughout December, including replays, Patreon teasers, deep cuts, and new interviews.He gives sobriety shoutouts — notably Lauren's three-year milestone and Maddie Veitch from Leftover Salmon celebrating her own recovery marker. He encourages listeners to email in clean-time milestones for future episodes.Dave then goes through a lengthy run of Spotify comments left on the Darrell Hammond episode. The comments range from people complaining about the “This or That” game, others defending it, jokes about possums, encouragement about psychedelics, questions about whether Darrell is truly sober, praise for the episode, frustration with the interview pacing, random remarks about Lime Drive and “Mike's Amazing Stuff,” plus multiple requests for stickers. Dave reads each comment and jokes along, sometimes offering to send merch.Ads for Mountainside and Link Diagnostics follow. Dave talks about how Mountainside is central to the history of Dopey and how Link Diagnostics offers drug testing services that help people “stay positive and test negative.”Dave then plays an LSD voicemail from Henry in San Francisco, who took two hits of acid alone in college. Henry becomes one with his bicycle, panics at a house fumigation tent he interprets as a circus, fears he'll be mutated by pesticides, runs home, listens to the Butthole Surfers, sees Aztec gods appearing from shifting ceiling patterns, and eventually rides it out. He is now 15 months sober and credits Dopey Nation for support.Next he reads an email from Jerry, who describes crazy addiction history including fighting cops on PCP, overdoses, ventilators, and robbing heroin dealers. Jerry discovered Dopey by typing “heroin” into the podcast search bar while newly out of rehab in 2018. His biggest complaint is that Dave has never watched Joe Dirt.The episode opens with your intro, then the bulk of the show is Hairy Tongue Will's massive, chaotic, detailed telling of his addiction, near-death runs, arrests, relapse cycles, dead friends, and eventual recovery.Will describes the early Long Island chaos with Richie, Mike, and Lenny—everyone strung out on heroin, crack, coke, and whatever they could get. He recalls the first serious turn: showing up to a house where Lenny was passed out after a three-day crack run, realizing “the demons are taking over.” Mike and Richie spiral deeper, and Will keeps managing to “hold it together” thanks to jobs, work ethic, and a strange electrical-job stabilizer that kept him semi-functional.He details years of DUIs, probation, manipulating drug tests, smoking crack constantly while still working 16-hour electrician shifts, and thriving socially because coworkers lived vicariously through him. He normalized chaos, missing only “one no-call/no-show every two weeks,” which he considered acceptable.Will then dives into his first short attempt at stability, living in a basement apartment. His probation officer surprises him the day after a holiday: the apartment is filled with beer cans, bongs, baggies. He fails the test, is sent back to rehab/jail cycles, and explains why Long Island addicts often choose jail over treatment. He describes his surreal time in jail—being sent to the Montauk Lighthouse on work crews, eating egg sandwiches and black-and-milds with the guards, becoming “the useful guy,” actually feeling respected and purposeful.Back outside, he tries again, fails again, collects DUIs, cycles through companies, loses jobs, hustles side work, and repeatedly relapses. A wedding night leads to another DUI. COVID hits while he's in jail. He gets out, starts working nonstop, earns money, piles cash in a closet, stacks crypto, reads self-help books, sleeps on a mattress on the floor, becomes obsessed with success and control.Then he meets a girl in Tennessee. He drinks again “successfully” only when he flies there. He builds a double life—working himself numb, drinking out of state, convincing himself he's different.Eventually, on a work trip, he gambles, wins big, drinks an old fashioned, and secretly cooks his boss's cocaine into crack. This reignites the obsession. Will starts traveling the Northeast and Midwest, repeatedly pulling crack-seeking missions: gas stations, high-crime neighborhoods, asking strangers, “I'm looking for some hard.” He builds drug contacts in Bridgeport, Dayton, Maine, Virginia, wherever the job sends him. He smokes in hotels, hallucinates blood on floors, changes rooms repeatedly.He recounts the deaths of friends:Mike, whose father turned their home into a sheet-walled trap house with dealers and bikers living inside.How Mike died with his father selling sneakers off his dead son's body.Richie, who got sober then died of fentanyl after nearly two years clean.Will's life collapses further—obsession, resentment toward God, jealousy, terminal uniqueness. He becomes a “demon,” wanting to die like his friends. He terrifies his girlfriend with delusional FaceTimes, nine-day runs, psychosis. She moves in without knowing the truth and becomes trapped in codependency.He stays high for 26 straight days, manipulates her with antihistamine allergy episodes to cover his psychosis, hides crack pipes around the house with ring cameras everywhere. He finally admits some truth, gives her $5,000 to escape, but she stays another nine months.He tells insane stories:Pretending he's a trust-fund baby to get free crackGetting shot at by a dealer after a misunderstanding over “two grams” vs “two ounces”Driving through wooded roads barefoot at gas stationsDealers trying to jump himBecoming a mule for a recently-released dealer (Ace)Near misses, violence, and pure street insanityEventually, during a pickup, he gets chased, prays for police lights, and his car breaks down. Cops descend. He gets a mountain of charges (“five decades worth”). He thinks he'll die in prison. Bail reform gets him released. He immediately uses again for 17 more days.A sober lawyer tries pushing him toward St. Christopher's. Will resists, manipulates LICR, relapses again, cancels his own insurance, tries to die, and after weeks of chaos his mother gets him re-approved. He enters St. Chris, still delusional, still dangerous.There he breaks. He admits suicidal thoughts, gets a guard stationed outside his door, hears the blunt truth—you're the worst-off guy here and you did this to yourself. It lands. Will begins working the program: spiritual direction, grief groups, codependency, meetings, kitchen duty, everything. He reconnects with his mother in sobriety. He attends court in suits provided by the facility and ultimately receives an unexpectedly generous plea deal.He comes home early, tries to run his own program, stays sober for months, but on Mother's Day runs into an old acquaintance who shows him a Newport box with a pipe inside. He relapses immediately for three days, misses Mother's Day entirely.That night, suicidal again, he receives a series of calls: first from Jordan, then from his tough sponsor, who gives him clear direction—go to a sober house, go to daily groups, go to nightly meetings, call people, build structure. Will frauds his urine to get in, but once inside, follows every instruction. He stabilizes.He recounts being 18 months sober now, having been at meetings nearly every night, with a recent slip in commitment due to chasing an “intimate partner godshot” that didn't work out. You reassure him that it's fine and that balance is part of recovery.More or less thats the whole thing! On a brand new fucko, crackead episode of that good old dopey show! Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
Na corrida para as presidenciais, as sondagens indicam três favoritos para as duas vagas da segunda ronda: André Ventura, Henrique Gouveia e Melo e Luís Marques Mendes. Os debates têm revelado algumas das estratégias dos candidatos e até já se ouvem apelos ao voto útil. No Bloco de Esquerda, a saída de Mariana Mortágua confirmou-se e é José Manuel Pureza que vai liderar os bloquistas. Daniel Oliveira acha que a esquerda está “assustada” com a hipótese de ter Ventura e Marques Mendes na segunda volta, Francisco Mendes da Silva acredita que António José Seguro já perder o embalo. Ouça a análise dos comentadores no Antes Pelo Contrário em podcast, emitido na SIC Notícias a 3 de dezembro. Para ver a versão vídeo deste episódio clique aquiSee omnystudio.com/listener for privacy information.
In our final topic of 2025 we explore what impacts the kids we care about in terms of their development and mental health. We explore the science and Dr Nick treats us to his big lessons from PCP this year. Please send in your best reflections, questions and advice for our reflection episode to share with the wonderful PCP community.
In this episode of The Fighter and the Kid, Brendan and Bryan sit down with comedian and wrestler Nick Simmons, who joins right as the guys finally address the years of Reddit hate, online criticism, and the wild narratives fans have created about the show.They dive into the hilarious but eye-opening ways women underestimate real strength, why self-defense fantasies don't match physics, and how pepper spray, bear spray, and knives work in real-world scenarios.Nick shares his insane PCP pandemic home-intruder story — including the break-ins, the stairwell fight, the loose slice of pizza, and the moment the cops let the guy go… right before he bit one officer's nose and an EMT's Achilles tendon.They compare this to the Anthony Smith intruder fight, breaking down why meth and PCP shut off the “governor” in the brain and create freak-level strength.From there, the guys get into Mongolian and Polynesian genetics, strength competitions, football concussions, stingers, and the brutal gap between normal athletes and genetic freaks.Nick also opens up about moving from NYC to Austin, meeting his girlfriend's intimidating dad, being a regular at iconic NYC clubs, and the new comedic grind of trying to get passed at The Comedy Mothership.The guys finish by roasting each other's outfits, shoes, and the chaos of performing comedy while your friends try to mess with your head backstage.A funny, honest, chaotic episode with one of the best young comics in Austin.DraftKings - Download the DraftKings Pick6 app now and use code FIGHTER. That's code FIGHTER — New DraftKings customers can play just $5, and get $50 in Pick6 credits.O'Reilly Auto Parts- https://oreillyauto.com/FIGHTERTrue Classic - True Classic - Upgrade your wardrobe and save on @trueclassic at https://trueclassic.com/fighter ! #trueclassicpodMagic Mind - https://magicmind.com/See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
Send us a textAt 2:17 on Thanksgiving Day 2025, Homily of Horrors entered it's 3rd season. Grab a gallon of PCP and join us as we take a dive into Zach Cregger's Sophomore film: Weapons.Music and sound effects are provided by zapslat.com and bensound.com, and the theme song is "Graveyard Shift" by Kevin MacLeod. https://creativecommons.org/licenses/by/4.0/
Curious whether red light therapy is actually legit—or just another wellness trend? In Episode 30, Allison interviews pelvic health physiotherapist Liz Frey, Director of Women's Health at Fringe, to explore the real science behind red and near-infrared light and how it may support pelvic floor function, postpartum recovery, perimenopause/menopause symptoms, pain, inflammation, and overall tissue health.We discuss how light therapy influences nitric oxide production, ATP and mitochondrial energy, circulation, collagen and elastin, and why vibration can help improve pelvic floor activation. Liz also explains blue light therapy for recurrent BV and yeast infections, plus practical tips for choosing between a wand, wrap, or panel.Limited-Time Sale (Nov 24–30): Save 25% off all Fringe red light products with code AllisonC25. Affiliate link: https://fringeheals.com/?ref=ALLISONECRAIG After Nov 30: save 10% anytime with AllisonC10.Affiliate Disclosure: We may earn a small commission if you purchase through these links at no extra cost to you.
Burnie and Ashley discuss Executive death threats, Starliner, Bitcoin crash, day trading, Scion fund closure, Wicked premiere, Titanic's PCP problem, and deli meats.
O desconto no IRS será para pensionistas portugueses no estrangeiro, que regressem a Portugal. Candidato do PCP a Belém defende mesas de voto em associações portuguesas no estrangeiro. Edição Isabel Gaspar Dias
The Kensington Philadelphia Drug Market, Real Story. If there is any place that captures the raw, unfiltered reality of America's drug crisis, it is The Kensington Philadelphia Drug Market. For decades, this neighborhood has been the epicenter of open-air dealing, addiction, and human suffering, an area where people lie on sidewalks, stumble through streets, and inject or smoke drugs in plain view. Sidewalks, parks, and alleys are littered with used needles. Crowds of people slump over, “nodded out,” as if frozen in time. Law Enforcement Talk Radio Show and Podcast social media like their Facebook , Instagram , LinkedIn , Medium and other social media platforms. “It's something you have to see to believe,” one writer observed. “Whatever you've seen on Twitter (X), Facebook, Instagram, or the evening news doesn't even come close.” The intense episode now streaming on the Law Enforcement Talk Radio Show and Podcast website, on Apple Podcasts, Spotify, YouTube, and most every major Podcast platform. A Marketplace of Desperation Kensington offers something few other places in America do, product variety. Fentanyl, now responsible for most overdose deaths, saturates the scene. Meth and crack mix in for users looking to combine “uppers and downers.” Even retro drugs like PCP have made a return. One user told investigators his typical order was “three down, one hard”, fentanyl for the down, crack for the hard. The Kensington Philadelphia Drug Market, Real Story. Look for supporting articles about this and much more from Law Enforcement Talk Radio Show and Podcast in platforms like Medium , Blogspot and Linkedin . This is the reality former Philadelphia warrant investigator Tristin Kilgallon witnessed firsthand. From the Streets to the Classroom Kilgallon, who grew up near Kensington, spent years navigating these streets as part of the First Judicial District's Warrant Unit. Once a frontline investigator tasked with tracking fugitives, he later left the unit to attend law school. He became a lawyer, then a criminal justice professor, teaching the next generation of justice professionals. “I loved the job, but the danger, the low pay, and the burnout, it wears you down,” Kilgallon explains. “Kensington changes you. You see things you can't unsee.” The Kensington Philadelphia Drug Market, Real Story. Available for free on their website and streaming on Apple Podcasts, Spotify, Youtube and other podcast platforms. He now speaks openly about the realities he observed, not just in policing but also in higher education. “There's a lot of myth versus reality in the classroom,” he says. “And too often, the focus is on political indoctrination, not actual education.” The Book: A Real Story of Crime, Chaos, and Brotherhood Kilgallon co-authored the book Philly Warrant Unit with lifelong friend and fellow investigator Mark Fusetti. The two grew up on the same block, reunited professionally years later, and began working side by side in one of America's toughest fugitive-tracking units. “This book isn't a traditional cover-to-cover read,” Kilgallon says. “It's a collection of true stories, intense, funny, tragic, and real.” The authors share behind-the-scenes experiences: tense arrests, tragic overdoses, unpredictable street encounters, and the kind of dark humor only law enforcement veterans understand. Their stories paint an unfiltered portrait of policing Philadelphia during a period when Kensington's drug market became a billion-dollar enterprise and a global symbol of urban decay. The Kensington Philadelphia Drug Market, Real Story. The Law Enforcement Talk Radio Show and Podcast episode is available for free on their website , Apple Podcasts , Spotify and most major podcast platforms. His interview can be found on The Law Enforcement Talk Radio Show and Podcast website, on Apple podcasts, Spotify, Youtube and on LinkedIn, Facebook, Instagram, and across most podcast platforms where listeners crave authentic law enforcement stories. Kensington: A Neighborhood Consumed Kensington was once a thriving industrial hub. When factories shut down during the 1960s and deindustrialization hollowed out the area, poverty, abandonment, and neglect took root. Vacant factories became havens for dealing and drug use. The Market-Frankford Line offered easy access. By the late 1990s, Kensington had become the place to buy heroin on the East Coast. As Kilgallon puts it: “The drug market didn't just appear, it grew like a parasite. And it's been feeding off the neighborhood for generations.” The full podcast episode is streaming now on Apple Podcasts, Spotify, and across Facebook, Instagram, and LinkedIn. Today, fentanyl, xylazine, meth, and crack dominate. Doctors and treatment centers struggle to help people addicted to substances that often leave them disfigured or near death. Residents face homelessness, encampments, violence, and crushing economic inequality. “Kensington has become the Las Vegas of Drugs,” Kilgallon says. “It's shocking, but it's the truth.” The Kensington Philadelphia Drug Market, Real Story. A Real Story Worth Hearing Kilgallon's firsthand insights, on policing, addiction, community collapse, and the failures of both policy and academia, make him a powerful voice in conversations about Kensington's future. His Real Story matters because it cuts through the political noise and media sensationalism. You can find the show on Facebook, Instagram, Pinterest, X (formerly Twitter), and LinkedIn, as well as read companion articles and updates on Medium, Blogspot, YouTube, and even IMDB. Whether you've seen snippets on X, listened to interviews on Apple Podcasts, streamed discussions on Spotify, or followed the dialogue on LinkedIn, one thing is clear: Kensington's crisis is not just a headline. It is a human story. A community story. A story with no easy answers. And as Kilgallon's book, career, and commentary show, the only way forward is through honesty, accountability, and a willingness to face the streets as they truly are. The Kensington Philadelphia Drug Market, Real Story. Available for free on their website and streaming on Apple Podcasts, Spotify, and other podcast platforms. Background song Hurricane is used with permission from the band Dark Horse Flyer. You can contact John J. “Jay” Wiley by email at Jay@letradio.com , or learn more about him on their website . Get the latest news articles, without all the bias and spin, from the Law Enforcement Talk Radio Show and Podcast on Medium , which is free. “If you enjoy the show,” John Jay Wiley adds, “please share it with a friend or two, or three. And if you're able to leave an honest rating or review, it would be deeply appreciated.” The Law Enforcement Talk Radio Show and Podcast is available for free on Apple Podcasts, Spotify, YouTube, and LETRadio.com, among many other platforms. Stay connected with updates and future episodes by following the show on Facebook, Instagram, LinkedIn, their website and other Social Media Platforms. Find a wide variety of great podcasts online at The Podcast Zone Facebook Page , look for the one with the bright green logo. Be sure to check out our website . Be sure to follow us on X , Instagram , Facebook, Pinterest, Linkedin and other social media platforms for the latest episodes and news. Listeners can tune in on the Law Enforcement Talk Radio Show website, on Apple Podcasts, Spotify, YouTube, and most every major Podcast platform and follow updates on Facebook, Instagram, and other major News outlets. You can find the show on Facebook, Instagram, Pinterest, X (formerly Twitter), and LinkedIn, as well as read companion articles and updates on Medium, Blogspot, YouTube, and even IMDB. You can help contribute money to make the Gunrunner Movie . The film that Hollywood won't touch. It is about a now Retired Police Officer that was shot 6 times while investigating Gunrunning. He died 3 times during Medical treatment and was resuscitated. You can join the fight by giving a monetary “gift” to help ensure the making of his film at agunrunnerfilm.com . The Kensington Philadelphia Drug Market, Real Story. Attributions Facebook Wikipedia Villanovan Philadelphia City Council City Journal Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
Movie Meltdown - Episode 651 (For our Patreon "Horror Club") Gather around the table with the beloved family members of the Horror Club as we celebrate Thanksgiving Jake-style. Together we discuss the state of the holiday season as well as the Thanksgiving classic Home Sweet Home starring Jake Steinfeld. And while we're trying to figure out family relations, we also cover… IT: Welcome To Derry, Doctor Sleep, Guillermo del Toro's Frankenstein, being addicted to PCP, close-up magic, Steve Guttenberg, Trapper Keeper artwork, Jacob Elordi, cutting someone's brakes for the holidays, a flexatone, hood kill, turkey-flavored Oreos, Mike Flanagan, a charming weirdo, death by smothering, Andy Muschietti, clown makeup guitar guy, warlock energy, Tryptophan, Scatman Crothers, watching surgery videos, Ready Player One, Mia Goth, running over an old lady, she's so Latin, bread in a can, Ace Frehley, Thanksgiving pizza flashbacks, dinner is not almost ready, Day of the Dead and does it come in a vial? Spoiler Alert: Full spoilers for the 1981 movie "Home Sweet Home"... you have been warned. "It's a weird world… and Jake was all up in it."
Neste episódio do Alta Definição, Paulo Raimundo é entrevistado por Daniel Oliveira, numa conversa que percorre a sua trajetória pessoal e profissional, desde a infância marcada por dificuldades económicas até à liderança política. O líder do Partido Comunista Português (PCP) partilha memórias familiares, experiências de trabalho, reflexões sobre educação, valores e desafios da vida quotidiana. Aborda ainda o impacto da sua atividade política na família, a importância da autenticidade e da luta coletiva, e destaca episódios marcantes que moldaram o seu percurso, fazendo a sua análise da realidade social portuguesa. * A sinopse deste episódio foi criada com o apoio de IA. Saiba mais sobre a aplicação de Inteligência Artificial nas Redações da Impresa ----O link para o estatudo editorial do Expresso: https://expresso.pt/sobre/estatuto-editorial/2020-01-20-estatuto-editorial-3c79f4ec O link para o estatudo editorial da SIC Notícias: https://sicnoticias.pt/institucional/2013-12-27-estatuto-editorial-sic-noticias-e84e2755 See omnystudio.com/listener for privacy information.
Oiça mais um episódio do Expresso da Meia-Noite, onde se debateu a polémica comparação histórica do 25 de Novembro ao 25 de Abril. O painel analisou as diferentes leituras políticas e históricas sobre o impacto destas datas na democracia portuguesa, destacando divisões partidárias e a complexidade da memória coletiva. Foram discutidos o papel dos militares, a influência do Partido Socialista e a necessidade de despolitizar o debate, sublinhando a importância de preservar uma visão crítica e pluralista da história recente de Portugal.See omnystudio.com/listener for privacy information.
Veja também em youtube.com/@45_graus Zita Seabra nasceu em 1949. Foi deputada à Assembleia da República de 1975 a 1988, coordenou o Secretariado Nacional para o Audiovisual em 1993, ano em que assumiu a presidência do Instituto Português de Cinema. De 1994 a 1995, foi presidente do Instituto Português da Arte Cinematográfica e Audiovisual. É editora e autora de Foi Assim (Alêtheia, 2007), onde partilha as suas memórias desde a infância até ao momento de ruptura com o Partido Comunista Português, altura em que publicou O Nome das Coisas (Publicações Europa-América, 1988). Desde 2005, dirige a Alêtheia Editores, da qual é fundadora, assim como a Várzea da Rainha Impressores. Há longos anos no meio editorial, foi editora da Quetzal e também administradora e directora editorial da Bertrand Editora. _______________ Índice: (0:00) Introdução (2:38) Como funciona por dentro um partido comunista? | Porque dá o Comunismo sempre em totalitarismo: é da ideologia ou do tipo de pessoa que permite chegar ao poder? (14:12) Porque foi do PCP diretamente para a direita? (22:51) Posição em relação ao aborto: no PCP e depois (28:52) O 25 de novembro | Livro Álvaro Cunhal - “Rumo à Vitória” | golpe militar va insurreição militar armadaSee omnystudio.com/listener for privacy information.
Veja também em youtube.com/@45_graus Zita Seabra nasceu em 1949. Foi deputada à Assembleia da República de 1975 a 1988, coordenou o Secretariado Nacional para o Audiovisual em 1993, ano em que assumiu a presidência do Instituto Português de Cinema. De 1994 a 1995, foi presidente do Instituto Português da Arte Cinematográfica e Audiovisual. É editora e autora de Foi Assim (Alêtheia, 2007), onde partilha as suas memórias desde a infância até ao momento de ruptura com o Partido Comunista Português, altura em que publicou O Nome das Coisas (Publicações Europa-América, 1988). Desde 2005, dirige a Alêtheia Editores, da qual é fundadora, assim como a Várzea da Rainha Impressores. Há longos anos no meio editorial, foi editora da Quetzal e também administradora e directora editorial da Bertrand Editora. _______________ Índice: (0:00) Introdução (4:32) O que atrai um(a) jovem no comunismo? | Comunismo vs maoismo vs trotskismo | Os totalitarismos e os perigos do intelectualismo excessivo (26:54) Quem militava naqueles partidos sabia o que se passava na URSS e na China maoista? | Porque o comunismo deu sempre em totalitarismo? (35:42) O que a fez a primeira vez duvidar, e como saiu do PCP? | Mikhail SuslovSee omnystudio.com/listener for privacy information.
Sócrates conquistou mais vinte dias. A juíza acabou por ter de lhe dar tempo para procurar advogado. E daqui a pouco mete-se o Natal e a Passagem de Ano. O Procurador-Geral da República afirmou que o processo “Influencer” ainda não avançou porque haveria um recurso a empatá-lo no Tribunal da Relação. Resposta da Relação: não temos cá recurso nenhum. Parece que foi resolvido em Setembro e ninguém avisou o PGR. Enquanto isso, UGT e CGTP convocaram uma greve geral. Montenegro acusa as centrais sindicais de estarem ao serviço dos interesses de PS e PCP. Se quiser ver o pacote laboral aprovado no parlamento só lhe resta o Chega. E Chega não se compromete esperando para ver em que param as modas. Jiga-jogas tácticas na semana em que o giga-ministro Matias prometeu giga-fábricas em Sines e uma liderança portuguesa da inteligência artificial a nível mundial. Giga-sonhemos, então.See omnystudio.com/listener for privacy information.
Shawn Tierney meets up with Henrik Pedersen and Jacob Abel to learn about OTee Virtual PLCs in this episode of The Automation Podcast. For any links related to this episode, check out the “Show Notes” located below the video. Watch The Automation Podcast from The Automation Blog: Listen to The Automation Podcast from The Automation Blog: The Automation Podcast, Episode 252 Show Notes: Special thanks to Henrik Pedersen and Jacob Abel for coming on the show, and to OTee for sponsoring this episode so we could release it “ad free!” To learn about the topics discussed in this episode, checkout the below links: OTee Virtual PLCs website Schedule an OTee demo Connect with Henrik Pedersen Connect with Jacob Abel Read the transcript on The Automation Blog: (automatically generated) Shawn Tierney (Host): Thank you for tuning back into the automation podcast. Shawn Tierney here from Insights. And this week on the show, I meet up with Henrik Pedersen and Jacob Abel to learn all about virtual PLCs from OTee. That’s o t e e. And, I just thought it was very interesting. So if you guys have ever thought about maybe running virtual PLCs to test some processes out, I think you’ll really enjoy this. With that said, I wanna welcome to the show for the very first time, Hendrik and Jacob. Guys, before we jump into your presentation and learn more about what you do, could you first introduce yourself to our audience? Henrik Pedersen (OTee): Yeah. Sweetly. So my name is Hendrik. I am the cofounder, COO, OT, a new industrial automation company, that, we’re really glad to present here today. I have a background from ABB. I worked eleven years at ABB. In terms of education, I have an engineering degree and a master degree in industrial economics. And, yeah, I’m I’m excited to be here. Thanks, Rom. And I’ll pass it over to Jake. Jacob Abel (Edgenaut): I’m, Jacob Abel. I’m the principal automation engineer at Edgnot. EdgeNaught is a systems integrator focusing on edge computing and virtual PLCs. My background is in mechanical engineering, and I’m a professional control systems engineer, and I have thirteen years experience in the machine building side of industrial automation, specifically in oil and gas making flow separators. And I’ll hand it back to Henrik here. Henrik Pedersen (OTee): K. Great. So OT, we are a a new industrial automation company, the new kid on the block, if you will. We’re a start up. So, we only started, about three years ago now. And, we focus solely on virtual PLCs and and the data architectures allow you to integrate virtual PLCs in in operations. And, you know, some of the listeners will be very familiar with this first, thing I’m gonna say, but I think it’s valuable to just take a take a little bit step back and and remember what has happened in in history when when it comes to to IT and OT and, and and what really what really happened with that split. Right? So it was probably around the ‘9 you know, around nineteen nineties where the the the domain computer science were really split into these two domains here, the IT and OT. And, and that, that was, that was kind of natural that that happened because we got on the, on the IT side of things, we got Internet, we got open protocols and, you know, we had the personal computers and innovation could truly flourish on the IT side. But whereas on the OT side, we were we were kind of stuck still in the proprietary, hardware software lock in situation. And and that has that has really not been solved. Right? That that that is still kind of the the situation today. And it this is what this is obviously what also, brought me personally to to really got really super motivated to solve this problem and and really dive deep into it. And I experienced this firsthand with with my role in NAD and, how how extremely locked we are at creating new solutions and new innovation on the OT side. So so we’re basically a company that wants to to truly open up the the the innovation in this space and and make it possible to adopt anything new and new solutions, that that sits above the PLC and and, you know, that integrate effectively to to the controller. So I I have this this, you know, this slide that kind of illustrates this point with with some some, you know, historical events or or at least some some some big shifts that has happened. And, Aurene mentioned a shift in nineteen nineties. And it wasn’t actually until ’20, 2006 that Gartner coined this term OT, to explain the difference really what what has happened. And and, you know, as we know, IT has just boomed with innovation since since the nineties and OT is, is, is slowly, slowly incrementally getting better, but it’s still, it’s still the innovation pace is really not, not fast. So, this is also, of course, illustrated with all the new developments in in GenAI and AgenTic AI, MCP, and things like that that is kinda booming on on the IT side of things. And and and yeah. So, but we do believe that there is actually something happening right now. And and we have data that they’re gonna show for for that. Like, the the large incumbents are now working on this as well, like virtual PLCs, software defined automation and all kinds of exciting things going on on the OT side. So we do believe that that we will see, we will see a shift, a true big shift on the OT side in terms of innovation, really the speed in which we can, we can improve and adopt new solutions on the OT side. And this is kind of exemplified by, like, what what is the endgame here? Like, you could say that the endgame could be that IT and OT once once again becomes the same high paced innovation domain. Right. But then we need to solve those underlying problems, the infrastructural problems that are still so persistent on the OT side of things. The fine point of this slide is to just illustrate what’s happening right now. It’s like cloud solutions for control is actually happening. Virtual PLC, software based automation, AI is happening all at once. And we see it with the big suppliers and and also the exciting startups that’s coming into this space. So I think there’s there’s lots of great excitement now that we can we can expect from the OT side, in in next few years. Shawn Tierney (Host): Yeah. You know, I wanna just, just for those listening, add a little, context here. If we look at 1980, why was that so important? Why is this on the chart? And if you think about it, right, we got networks like Modbus and, Data Highway in nineteen seventy eight, seventy nine, eighty. We also got Ethernet at that time as well. And so we had on the plant floor field buses for our controls, but in the offices, people were going to Ethernet. And then when we started seeing the birth of the public Internet, right, we’re talking about in the nineties, people who are working on the plant floor, they were like, no. Don’t let the whole world access by plant floor network. And so I think that’s where we saw the initial the the divide, you know, was 1980. It was a physical divide, just physically different topologies. Right? Different needs. Right? And then and and as the Internet came out in the early nineties, it was it was now like, hey. We need to keep us safe. We know there’s something called hackers on the Internet. And and I think that’s why, as you’re saying in 2006, when Gartner, you know, coined OT, we were seeing that there was this hesitant to bring the two together because of the different viewpoints and the the different needs of both systems. So I think it’s very interesting. I know you listeners, you can’t see this, but I kinda want to go back through that and kinda give some context to those early years. And and, you know, like Henrik says, you know, now that we’re past all that, now that we’re using Ethernet on the plant floor everywhere, right, almost everywhere, on all new systems, definitely, that that becomes the right now on this on the today on the, on the chart. And I’ll turn it back to you, Henrik. Henrik Pedersen (OTee): Yeah. I’ll search that. I just wanna echo that as I think that there are really good reasons for why this has happened. Like, the there has you could argue that innovation could flourish on the IT side because there was less critical systems, right, less, more, you know, you can do to fail fast and you can do, you can test out things on a different level. And so so there’s really lots of good reasons for why this has happened. We do believe that right now there is some really excitement around innovation, the OT side of things and and this pent up kind of, I wouldn’t call it frustration, but this pent up potential, I think is the right word, is is can be kind of unleashed in our industry for for the next, next decade. So so we are like this is really one of the key motivators for me personally. It’s, like, I truly believe there’s something truly big going on right now. And and I I do I do encourage everyone, everyone listening, like, get in get in on this. Like, this is happening. And, you know, be an entrepreneur as well. Like, build your company, build and, you know, create something new and exciting in this space. I think I think this is this is a time that there hasn’t been a better time to create a new new technology company or a new service company in this space. So this this, this is something at least that motivates me personally a lot. So let me move over to kind of what we do. I mentioned I mentioned that we focus solely on the virtual PLC. This this is now presented in the slide for those that are listening as a as a box inside a open hardware. We can deploy a virtual PLC on any, ARM thirty two thirty two and and sixty four bit processor and x eighty six sixty four bit with the Linux kernel. So so there are lots of great, options to choose from on the hardware side. And and, and yeah. So you can obviously when you have a Virtual PLC you can think of it new in terms of your system architecture. You could for instance, you know deploy multiple Virtual PLCs on this on the same hardware and you can also, think about it like you can use a virtual PLC in combination with your existing PLCs and could work as a master PLC or some kind of optimization deterministic controller. So it’s it’s really just opening up that, you know, that architectural aspect of things. Like you can think new in terms of your system architecture, and you have a wide range of hardware to choose from. And, and yeah, So the the flexibility is really the key here, flexibility in how you architect your system. That CPU that you deploy on will will obviously be need to be connected to to the field somehow, and that’s that’s true, classical remote IO, connections. So we currently support, Modbus TCP and Ethernet IP, which is kind of deployed to to, our production environment, as it’s called. So moving on to the next slide. Like, this is kind of the summary of our solution. We have built a cloud native IDE. So meaning anyone can can basically go to our website and log in to into the solution and and give it a spin. And, we’ll show you that afterwards with with Jake. And the system interacts through a PubSub data framework. We use a specific technology called NUTS, for the PubSub communication bus. And you can add MQTT or OPC UA to the PubSub framework, according to your needs. So, and from that, you can integrate with, whatever whatever other, software you might have, in your system. So we have these value points that we always like to bring up. Like, this obviously breaks some kind of vendor lock in in terms of the hardware and the software. But it’s also, our virtual PLC is based on on the six eleven thirty one. So it’s not a lock in to any kind of proprietary programming language or anything like that. There is, there’s obviously the cost, element to this that you can potentially save a lot of cost. We have, we have verified with with with some of our customers that they estimate to save up to 60% in total cost of ownership. This is there is obviously one part is the capex side and the other part is is the opex. And and is this data framework, as I mentioned, is in in in which itself is is future proof to some extent. You can you can integrate whatever comes comes in in a year or or in a few years down the line. And, there’s environmental footprint argument for this as you can save a lot on the on the infrastructure side. We have one specific customer that estimates to save a lot on and this this particular point is really important for them. And then final two points is essentially that we have built in a zero trust based security, principle into this solution. So we have role based access control. Everything is encrypted end to end, automatic certification, and things like that. The final point is, is that this is the infrastructure that allows you to bring AI and the classical, DevOps, the the thing that we’re very used to in the IT side of things. Like, you you commit and merge and release, instead of, instead of the traditional, way of working with your automation systems. So I know this is like, this is pro pretty much, like, the boring, sales pitch slide, but, but, yeah, I just wanted to throw this this out there for for the guys that there is some there is some, intrinsic values underneath here. The way the system works, you will you will see this very soon, through the demo, but it’s basically you just go to a website, you log in, you create a project. In there, you would create your your PLC program, test, you code, you simulate. You would onboard a device. So onboard that Linux device that you you want to deploy on. This can be as simple as a Raspberry Pi, or it can be something much more industrial grade. This depends on on on the use case. And then you would deploy services like, as I mentioned, MQTT and OPC UA, and then you would manage your your your system from from the interface. And, I have this nice quote that we got to use from one of the customers we had. This is a global, automotive manufacturer that, basically tells us that it’s, they they highlighted the speed in which you can set this up, as as one of the biggest values for them, saving them a lot of hours and setting setting up the system. So I also wanted to show you a real you know, this is a actual real deployment. It was it was deployed about a year ago, and this is a pump station, or a water and wastewater operator with around 200 pump stations. They had a mix of of Rockwell and Schneider PLCs, and they had a very high upkeep, and they were losing a lot of data from these stations because they were connected over four g. When the Internet was a bit poor, they lost a bit of data in their SCADA systems, so they had these data gaps and things like that. So pretty pretty, you know, standard legacy setup to be to be honest. Quite outdated PLCs as well. So what they what they did for the first, pump station was they they, you know, removed the PLC. They put in a Raspberry Pi for for, like, €60 or, like, $70, connected it to to a to a remote IO Ethernet IP module they had, in in the storage, and deploy this data framework as I’m showing on the screen now. So so they that was that was the first station they put online, and they they chose a Raspberry Pi because they thought, okay, this is interesting, but will it work? And then they chose a pump station, which was was really just poor from before. So they had very little to to to lose to to deploy on this station. So so, yeah, this has been running for a year now without any any problems on a Raspberry Pi. We have obviously advised against using a Raspberry Pi in a critical environment, but they just insisted that that what that’s what they wanted to do for this first case. Shawn Tierney (Host): And I’ll back that up too. Your generic off the shelf Raspberry Pi is just like a generic off the shelf computer. It’s not rated for these type of environments. Not that all pump houses are really bad, but they’re not air conditioned. And I think we’ve all had that situation when it’s a 120, 130 out that, you know, off the shelf computer components can act wonky as well as when they get below freezing. So just wanted to chime in there and agree with you on that. For testing, it’s great. But if you’re gonna leave it in there, if you were in my town and you say you’re gonna leave that in there permanently, I would ask to have you, assigned somewhere else for the town. Henrik Pedersen (OTee): Yeah. Yeah. Exactly. No. So and and that point is also illustrated with the second station they brought online. So there they chose a much more industrial grade CPU, that, that, was much, you know, cost cost a bit more, but it’s more suited for the environment. And, and yeah. So this was, I can disclose it was a Bayer Electronics, CPU. So so yeah. And, and they reported, some good, good metrics in terms of, like, the results. They they said around 50 on the hardware, 75% on the management of the PLC system. So this relates more to that they have very a lot of, you know, driving out with the car to these stations and doing changes to their systems and, and updates. They no longer have any, any data loss. It’s local buffer on the data framework. They’ve increased tag capacity with 15 x, resulting in in four fifty five x better data resolution and a faster scan frequency. And this is actually on the Raspberry Pi. So so just just think of it as as the the even the even the, kind of the lowest quality IT off the shelf, computers, are are able to to, to execute really fast in in in, or fast enough for for, for these cases. So, Shawn, that was actually what I wanted to say. And, and also, you know, yeah, we are we are a start up, but we do have, fifth users now in 57 different countries across the world. And it’s it’s really cool to see our our our, our technology being deployed around the world. And, and yeah. I’m really, really excited to to, to get more, users in and and hear what they what they, think of the solution. So so yeah. I’ll I’ll with that, I don’t know if, Shawn, you wanna you shoot any questions or if we should hand it over to Jake for for for a demo. Shawn Tierney (Host): Yeah. Just before we go to Jake, if somebody who’s listening is interested, this might be a good time. It said that, you already talked about being cloud based. It’s, o t e e. So Oscar Tom, Edward Edward for the the name of the company. Where would they go if if they like what Jake’s gonna show us next? Where will they go to find out more? Henrik Pedersen (OTee): Yeah. So I would honestly propose that they just, reach out to to me or Jake, on on one of the QR codes that we have on the presentation. But they can also obviously go to our website, 0t.io,0tee.io, and just, either just, log in and test the product, or they could reach out to us, through our website, through the contact form. So yeah. Shawn Tierney (Host): Perfect. Perfect. Alright, Jake. I’ll turn it over to you. Jacob Abel (Edgenaut): Thanks, Shawn. Fantastic stuff, Henrik. I wanna take a second too to kinda emphasize some of the technical points that you, presented on. Now first, the the fact that you have the built in zero trust cybersecurity is so huge. So, I mean, the OT cybersecurity is blowing up right now. So many certifications, you know, lots of, consulting and buzz on LinkedIn. I mean, it’s a very real concern. It’s for a good reason. Right? But with this, zero trust built in to the system, I I mean, you can completely close-up the firewall except for one outgoing port. And you have all the virtual PLCs connected together and it’s all done. You know, there’s no incoming ports to open up on the firewall to worry about, you know, that security concern. You know, it’s basically like, you know, you’ve already set up a VPN server, if you will. It’s it’s not the same, but similar and, you know, taking care of that connection already. So there’s an immense value in that, I think. Shawn Tierney (Host): And I wanted to add to the zero trust. We’ve covered it on the show. And just for people, maybe you’ve missed it. You know, with zero trust is you’re not trusting anyone. You authorize connections. Okay? So by default, nobody’s laptop or cell phone or tablet can talk to anything. You authorize, hey. I want this SCADA system to talk to this PLC. I want this PLC to talk to this IO. I want this historian to talk to this PLC. Every connection has to be implicitly I’m sorry. Explicitly, enabled and trusted. And so by default, you know, an an integrator comes into the plant, he can’t do anything because in a zero trust system, somebody has to give him and his laptop access and access to specific things. Maybe he only gets access to the PLC, and that makes sense. Think about it. Who knows whether his laptop has been? I mean, we’ve heard about people plug in to the USB ports of the airport and getting viruses. So it’s important that person’s device or a SCADA system or a historian only has access to exactly what it needs access to. Just like you don’t let the secretary walk on the plant floor and start running the machine. Right? So it’s a it’s an important concept. We’ve covered it a lot. And and, Jake, I really appreciate you bringing that up because zero trust is so huge, and I think it’s huge for OT to have it built into their system. Henrik Pedersen (OTee): Yeah. Absolutely. Absolutely. Jacob Abel (Edgenaut): I wanted to highlight too the Henrik mentioned that the the backbone of the system is running on a technology called NATS. That’s spelled n a t s. And why that’s important is this is a a lightweight messaging, service, and it’s designed to send millions of messages per second. You know, that’s opposed to, you know, probably the best Modbus TCP device that you can find. You might get a couple 100 messages through per second. It’s millions of messages per second. It’s, you know, especially with, you know, we’re dealing with AI machine learning, you know, training models. I mean, we’re data hungry. Right? So this gives you the backbone too. You know, it’s like it can push an immense amount of tag data, you know, with ease. I think that’s another really important point. With that, though, I’ll I’ll get on to the demo. Henrik Pedersen (OTee): Oh, that’s great. We do we do see that, Jay, that most of our customers report on that, you know, 400 or 700 x better data resolution. And so it’s it’s a step change for for for the data resolution there. Yeah. Jacob Abel (Edgenaut): Excellent. So one of the things that I personally love about OT is how quickly you can get into the PLC once everything’s set up. So this is OT’s website, obviously, ot.io. So once you’re here, you just go to log in. And that brings in the login screen. Now I’m are I’m using my Google account for single sign on, so I can just click continue with Google. And this brings me into the main interface. And another thing that I love is that, you know, it is very simple and straightforward, you know, and simple is not a bad thing. Simple is a good thing. I mean, the way that things should be is that it should be, it should be easy and the finer details are taken care of for you. So right here, we have our main project list. I just have this one benchmarking program that I’ve imported in here. And you also have device lists, just a a test device that I’ve installed the runtime on. Just real quick. You know, you have a Martha, the AI assistant in the corner here. And, the documentation guides is up here. So you can get help or look into reference material very easily. It’s all right there for you. So I’m gonna open up this program here. So just a quick tour here. Right up here in the top left is basically where where most everything’s done. So if you click on this little down arrow, you can choose what virtual PLC runtime to attach it to. I’ve already attached it to the device. I installed the runtime on. You can add, you know, a new program, driver, function blocks, custom data types real quick here. Compile your program, download it to the device. Check the release history, which is really, really great. As you can, you can go into release history and you can revert to a prior version very easily. We got built in, version control, which is another, great feature. Henrik Pedersen (OTee): I can also just comment on that, Jake, that we do have we do have, in the quite short term roadmap to also expand on that with Git integration, that, a lot of our customers are are asking for. So yeah. Jacob Abel (Edgenaut): Awesome. Yeah. I mean, that’s that’s another, very hot topic right now. It’s, you know, getting getting the revision control systems, as part of, you know, at least the textual, programming languages. See, so, you know, we have a few, like, housekeeping things here. I mean, you can delete the program, export it. It’s a good good point here is that, OT complies with the PLC open, XML specification. So you can import or export programs, in this XML format, and it should work with solid majority of other automation software out there. You know, if you need to, you want to transition over to OT, you know, you can export it from your other software and import it rather easily. Got your program list here and, you know, just the basic configuration of, you know, you can add global variables that you wanna share between the different programs and POUs or, you know, change the, cycle rate of the periodic tasks, add more tasks. Let’s just get jump into this program here. Both the system uses the IEC sixty one one thirty one dash three standard structured text. So here’s just a little, quick benchmark program that I’ve been using to do some performance testing. Like you, you have the, the code right here, obviously. And on our, our right, the variable list, very easy to add a new variable and pick out the type. You can set a set of default value, add some notes to it. Super easy. So let’s go online. So if you have these little glasses up here in the top, right, you display live tag values. And so it’s grabbing from the runtime that’s running and plopping it right in here in the editor, which I I love the way it’s displayed. It makes it. And, you know, it’s one of the question marks is if you’re doing structured text instead of letter logic, like how it’s gonna show up and how readable is it gonna be. I think the, the text, like the color contrast here helps a lot. It’s very, very readable and intuitive. And we also have the tag browser on the right hand side. Everything is, organized into, you know, different groups. There’s the the resources and instances that you’ve set up in the configuration tab. So the by default, the tag the tags are all listed under there. And here too, you know, you can set tag values doing some performance testing, as I said. So this is, recording some some jitter and task time metrics. And that’s that’s really it. That’s the that’s the cloud IV in a nutshell. Super easy, very intuitive. I mean, it’s there there’s zero learning curve here. Shawn Tierney (Host): For the, audio audience, just a little comment here. First of all, structured text to me seems to be, like, the most compatible between all PLCs. So, you know, everybody does ladder a little bit differently. Everybody does function blocks a little bit differently. But structured text and, again, I could be wrong if you guys think out there in the in listening, think I’m wrong about that. But when I’ve seen structured text and compared it between multiple different vendors, it always seems to be the closest from vendor to vendor to vendor. So I can see this makes a great a great place to start for OT to have a virtual PLC that supports that because you’re gonna be able to import or export to your maybe your physical PLCs. The other thing is I wanted to comment on what we’re seeing here. So, many of you who are familiar with structured text, you know, you may have an if then else, or an if then. And and you may have, like, tag x, equals, you know, either some kind of calculation, you know, maybe, you know, z times y or just maybe a a constant. But what we’re seeing here is as we’re running, they have inserted at a in a different color the actual value of, let’s say, tag x. So in between you know, right next to tag x, we see the actual value changing and updating a few times a second. And so it makes it very easy to kinda monitor this thing while it’s running and see how everything’s working, and I know that’s that’s huge. And I know a lot of vendors also do this as well, but I love the integration here, how it’s so easy to see what the current values are for each of these variables. And, I’ll turn it over to you, Hendrick. I think I interrupted you. Go ahead. Henrik Pedersen (OTee): Yeah. No. I was just gonna comment on that. Jake said, like, this is the this is the POC editor, and the next the next big feature that we’re releasing very soon is essentially the service, manager, which is the, which is the feature that will allow our users to deploy any kind of service very efficiently, like another runtime or OPC UA server or an entity server or or or whatever other, software components that that, you want to deploy, like a Knox server or things like that. So and that’s that’s, we were really excited about that because, that will kind of allow for a step change in how you kind of orchestrate and manage your system and your, your system and your, your, you have a very good overview of what’s going on with versions of, of the different software components running in your, your infrastructure and your devices and things like that. So we’re really excited about that, that it’s coming out. And it might be that actually when when this, episode airs, who knows if it’s if it’s done or or not, but we’re very close to release the first version of that. So excited about that. Shawn Tierney (Host): Now I have a question for you guys, and maybe this is off topic a little bit. So let’s say I’m up here in the cloud. I’m working on a program, and I have some IO on my desk I wanna connect it to. Is that something I can do? Is there a connector I can download and install my PC to allow the cloud to talk to my IO? Or is that something where I have to get a a, you know, a local, you know, like we talked about those industrial Linux boxes and and test it here with that? Henrik Pedersen (OTee): Yeah. So I think you what you what you’re you’re after is, like, the IO configuration of, if you wanna deploy a driver, right, or, like, a modbus driver and how you figure out the system. Right? Shawn Tierney (Host): Yeah. Because this is in the cloud. It’s not on my desk. The IO is on my desk. So how would I connect the two of them? How would I is is that something that can be done? Henrik Pedersen (OTee): Yep. Yeah. Exactly. That’s that’s actually the you know, I I think, Jake, you might just wanna show why you deploy a driver. Right? Jacob Abel (Edgenaut): Sure. Sure. And I just wanna take a second to, clarify. You know, it’s something that kinda comes up often, and I I don’t I don’t think it gets it’s it’s cleared up enough is that so, you know, we have this cloud ID here. So, you know, you can open this from anywhere in the world. But the virtual PLC run times get installed on computers preferably very locally, you know, on the machine, on the factory floor, something like that. I I’ve got, an edge computer right here. Just as an example. I mean, this is something you would just pop in the control panel and you can install OT on this. So to answer your question better, Shawn, you know, to get to, you know, the remote IO that you need essentially, or actually in the, in the case of this, this has onboard IO. You know, you’re looking at connecting with MOBAs, PCP, Ethernet IP. I I know that a lot more protocols are coming. Profinet. So how you would do that is that you have that plus sign up here and add a driver config. We’re just gonna do, Modbus real quick. Henrik Pedersen (OTee): Mhmm. Jacob Abel (Edgenaut): And we wanna add a TCP client. So you can name the client, tell it how fast to pull, you know, any delays, put in the IP address. Just an example. Do the port number if you need and then add your requests. You know, you have support for, all the main function codes and mod bus right here, you know, read holding, read input, you know, write multiple coils, all that good stuff, you know, tell address how many registers you wanna do, timeouts, slave ID. And then, you know, once you’ve done that, so let’s say, you know, I’m gonna read, and holding registers here, the table on the right auto updates. You can do aliases for each one of these. You can just do register one Mhmm. As an example Shawn Tierney (Host): It’s showing just for the audio audience, it’s showing the absolute address for all these modbus, variables and then, has the symbols, and he’s putting in his own symbol name. It has a default symbol name of symbol dash something, and he’s putting his own in, like, register one, which makes it easier. Yeah. Jacob Abel (Edgenaut): Good point. Yeah. Good point. Thanks, Shawn. So, yeah, once once you put in your request and you can throw in some aliases, for the different registers, you know, you can go back to your program and here’s this, sample variable that I just added from earlier. You know, you can the registers are 16 bits. I’m gonna select, an int. And what you can do here now is select those modbus requests that you just set up. So it automatically maps these to those variables for you. So that that way you don’t have to do anything anything manual, like have a separate program to say, you know, this tag equals, you know, register 40,001. You know, it’s already mapped for you. So that’s that’s essentially how you would connect to remote IO is, just add a client in the driver configs and, fill in all your info and be off and running. Shawn Tierney (Host): That’s excellent. I really liked how you were able to easily map the register to the modbus value you’re reading in or writing to to your, variable so you can use that in your program. That was very easy to do. Jacob Abel (Edgenaut): Oh, yeah. Yeah. It’s that it’s like I said, that’s one of the things that I love about this interface is that everything is just very straightforward. You know, it’s it’s super easy to just stumble upon whatever it is you need and figure it out. Henrik Pedersen (OTee): And just just, to add to to kinda your your processors, like, once you have created that connection between the IO and and and the program, you basically just, compile it and download it to the to the runtime again, and and it executes locally the based on the yeah. Nice. Jacob Abel (Edgenaut): Oh, right. Good point. Yeah. Of of course, after we add something, we do have to redownload. So Shawn Tierney (Host): Very interesting. Well, that answers my question. Jacob Abel (Edgenaut): I think that’s that’s about it for the the demo. I mean, unless, Shawn, you have any more questions about the interface here. Shawn Tierney (Host): No. It looked pretty straightforward to me, Hendrik. I don’t know. Did you have anything else you wanted to discuss while we have the demo up? Henrik Pedersen (OTee): Nope. Not nothing related to this except for that, you know, this is probably something that’s quite new in the OT space is that this is a software service, meaning that there are continuous development going on and releases, and improvements to the software all the time. Like literally every week we deploy new improvements. And, and what, I typically say is that like, the, you know, if you if you if you sign up with OT, what you what you will experience is that the actual software keeps on becoming better over time and not is not going to become outdated. It’s going to be just better over time. And I think that’s part of what I really loved about the innovation space, innovation happening around IT is that that, that has become the new de facto standard in how you develop software and great software. And I think we in, in, in the OT space, we need to adopt that same methodology of developing software, something that continuously becomes better over time. Shawn Tierney (Host): Yeah. And I would just say, you know, if you’re if you’re on the OT side of things, you wanna be in six eleven thirty one dash three languages, because these are things that your staff, you know, what you know, your electricians and technicians and even engineers, you know, should know, should be getting up to speed. I don’t know. We’re at the automation school. We’re teaching, structured text. And so, easier. I look at this, and I’m like, this is a lot easier than trying to learn c plus or or JavaScript. So in any case, I think, you know, if it’s an OT side real IO control, real control system or data collection, you know, you know, very important, you know, mission critical data collection, then, you know, I’d rather have this than somebody trying to write some custom code for me and, you know, use some kind of computer language who doesn’t understand, you know, the OT side of things. So, I could definitely see the advantage of your system, Henrik. Henrik Pedersen (OTee): Yep. I I I also wanted to say to that, Stike, the I I do not believe the EIC standards in general will disappear. They exist for a very good reason. Right. Exists to standardise to to ensure safety and determinists, determinism in this. So I don’t think they will disappear. But there are obviously advances now with AI and things like that that can can help us create these things much faster and much more efficient and things like that. So, so but, but the EIC standards, I think, will be there for a very long time. Obviously, the 06/4099 standard is is really exciting, and and we believe that that can be, yeah, that that can clearly be there, but it’s still a new EIC standard. So, Shawn Tierney (Host): it’s not think what we’re gonna see is we’re gonna see a lot more libraries fleshed out. There’ll be a lot less writing from scratch. We’ve interviewed on the History of Automation podcast. We’ve interviewed some big integrators, and they’re at a point now, you know, twenty, thirty years on that they have libraries for everything. And I think that’s where we’ll see, you know, much like the DCS, I think, vendors went two years ago. But I still think that the there’s a reason for these languages. There’s a reason to be able to edit things while they run. There’s a reason for different languages for different applications and different, people maintaining them. So I agree with you on that. I don’t I don’t think we’re we’re gonna see the end of these, these standard languages that have done us very well since the, you know, nineteen seventies. Jacob Abel (Edgenaut): I just wanna add a bit on there about, Shawn, you mentioned, you know, doing less code. I I did show earlier in the bottom right hand corner here, we have our our little AI assistant, Martha. I don’t believe the feature, it has been released yet. You know, Henrik, correct me if I’m wrong, but I know one of the things that’s coming is, AI code generation, you know, similar to that of cloud or chat GPT. So it’s going to, you know, you can open this guy up here. You know, right right now, I think it’s just for, help topics, but you’ll be able to talk to Martha and she’s gonna generate code for you in your program there all built in. Henrik Pedersen (OTee): Yeah. Yeah. That’s that’s coming really fast now. So, it’s it’s not been implemented yet, but it’s, it’s right around the corner. Shawn Tierney (Host): Yeah. And it’s it’s not gonna be able to it’s you’re not gonna be able to hook a camera up to it and, like, take pictures of your machine and say, okay. Write the control code for this. But, you know, if you had a, you know, process that had 12 steps in it, the AI could definitely help you generate that code and and other code. And we’ll have to have Henrik and Jake back on to talk about that when it comes out, but, you know, it’s gonna be able to save you, reduce the tedious part of the the coding. You know, if you need an array of so many tags and so many dimensions or, you know, the stuff that, you know, it would just be the typing intensive, it’s gonna be able to help you with that, and then you can actually put the context in there. Just like, you can pull up a template in Word for a letter, and then you can fill in the blanks. You know? And and, of course, AI is helping make that easier too. But, in any case, Henrik, maybe you can come back on when that feature launches. Henrik Pedersen (OTee): Yeah. Absolutely. And I’m also excited about just a simple a use case of of translating something. Right? Translating your existing let’s say if it’s a proprietary code or something like that, like, getting it getting it standardized and translating it to the ESE six eleven thirty one standard, for instance, or, so so the obviously AI is, like, perfect for this space. It’s there is no doubt, And and it’s, like, that’s also why I’m so excited about, like, what’s going on at the moment. It’s like there’s so much innovation potential, in the on the OT side now that, they are with all these new technologies. Shawn Tierney (Host): Yeah. Absolutely. Absolutely. Well, gentlemen, was there anything else you wanted to cover? Henrik Pedersen (OTee): I think just just one final thing from from me is, like, we thought a lot about it, like, before this this episode, and we thought, like, let’s offer let’s offer the listeners something something of of true value. So so we thought, the, you know, after this after this episode launched, we want to want to offer anyone out there that’s listening a free, completely hands on trial of our technology, in their in their in their environment or on their Raspberry Pi or whatever. So just just reach out to us if you wanna do that. And, and I yeah. We’ll get you set up for for for testing this, and it’s not gonna cost you anything. Shawn Tierney (Host): Well, that’s great. And, guys, if you’re listening, if you do take advantage of that free trial, please let me know what you thought about it. But, Henrik, thank you so much for, that offer to our listening audience. Guys, don’t be bashful. Reach out to him. Reach out to Jake. Jake, thank you for doing the demo as well. Really appreciate it. My pleasure. Any final words, Henrik, before we close out? Henrik Pedersen (OTee): No. It’s been great. Great, being here, Shawn, and thanks for for helping us. Shawn Tierney (Host): Well, I hope you enjoyed that episode. I wanna thank Hendrik and Jacob for coming on the show, telling us all about OT virtual PLCs, and then giving us a demo. I thought it was really cool. Now if any of you guys take them up on their free trial, please let me know what you think. I’d love to hear from you. And, with that, I do wanna thank OT for sponsoring this episode so we could release it completely ad free. And I also wanna thank you for tuning back in this week. We have another podcast coming out next week. It’ll be early because I will be traveling and doing an event with a vendor. And so expect that instead of coming out on Wednesday to come out on Monday if all goes as planned. And then we will be skipping the Thanksgiving, week, and then we’ll be back in the in the, in December, and then we have shows lined up for the new year already as well. So thank you for being a listener, a viewer, and, please, wherever you’re consuming the show, whether it’s on YouTube or on the automation blog or at iTunes or Spotify or Google Podcasts or anywhere, please give us a thumbs up and a like or a five star review because that really helps us expand our audience and find new vendors to come on the show. And with that, I’m gonna end by wishing you good health and happiness. And until next time, my friends, peace. Until next time, Peace ✌️ If you enjoyed this content, please give it a Like, and consider Sharing a link to it as that is the best way for us to grow our audience, which in turn allows us to produce more content
(00:00-17:49) If you see Tim out and about on trashed Tuesday, just celebrate in silence. Not sure there's a fit with Kyrou and the Maple Leafs right now. Jackson is responding through drops. Tim wants 364 designated as the best road in all of St. Louis. STOP TELLING PEOPLE ABOUT 364. Jackson loves autumnal drives and fall sunsets. PCP's got a nice ass. Getting deported from Cottleville.(17:57-19:56) Continuing the horny music theme.(20:06-35:46) Doug, what about that Fiona Apple? How do tornados work? We respect golf course employees and their airhorns. Audio of Danny Kanell saying he's done with a G5 team getting an autobid into the College Football Playoffs. The five-seed is the sweet spot to be in for the CFP. Is Lex Luthor playing a character? Jackson was the first to announce the Brian Daboll firing.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
Put on your flotation devices and keep an eye on the catering table, because today, we're getting a broader understanding of what happened on the set of Titanic when around 80 cast and crew members were drugged with PCP on the last night of filming in Nova Scotia Become a supporter of this podcast: https://www.spreaker.com/podcast/broads-next-door--5803223/support.
Listen to JCO's Art of Oncology article, "The Man at the Bow" by Dr. Alexis Drutchas, who is a palliative care physician at Dana Farber Cancer Institute. The article is followed by an interview with Drutchas and host Dr. Mikkael Sekeres. Dr. Drutchas shares the deep connection she had with a patient, a former barge captain, who often sailed the same route that her family's shipping container did when they moved overseas many times while she was growing up. She reflects on the nature of loss and dignity, and how oncologists might hold patients' humanity with more tenderness and care, especially at the end of life. TRANSCRIPT Narrator: The Man at the Bow, by Alexis Drutchas, MD It was the kind of day that almost seemed made up—a clear, cerulean sky with sunlight bouncing off the gold dome of the State House. The contrast between this view and the drab hospital walls as I walked into my patient's room was jarring. My patient, whom I will call Suresh, sat in a recliner by the window. His lymphoma had relapsed, and palliative care was consulted to help with symptom management. The first thing I remember is that despite the havoc cancer had wreaked—sunken temples and a hospital gown slipping off his chest—Suresh had a warm, peaceful quality about him. Our conversation began with a discussion about his pain. Suresh told me how his bones ached and how his fatigue left him feeling hollow—a fraction of his former self. The way this drastic change in his physicality affected his sense of identity was palpable. There was loss, even if it was unspoken. After establishing a plan to help with his symptoms, I pivoted and asked Suresh how he used to spend his days. His face immediately lit up. He had been a barge captain—a dangerous and thrilling profession that took him across international waters to transport goods. Suresh's eyes glistened as he described his joy at sea. I was completely enraptured. He shared stories about mornings when he stood alone on the bow, feeling the salted breeze as the barge moved through Atlantic waves. He spoke of calm nights on the deck, looking at the stars through stunning darkness. He traveled all over the globe and witnessed Earth's topography from a perspective most of us will never see. The freedom Suresh exuded was profound. He loved these voyages so much that one summer, despite the hazards, he brought his wife and son to experience the journey with him. Having spent many years of my childhood living in Japan and Hong Kong, my family's entire home—every bed, sheet, towel, and kitchen utensil—was packed up and crossed the Atlantic on cargo ships four times. Maybe Suresh had captained one, I thought. Every winter, we hosted US Navy sailors docked in Hong Kong for the holidays. I have such fond memories of everyone going around the table and sharing stories of their adventures—who saw or ate what and where. I loved those times: the wild abandon of travel, the freedom of being somewhere new, and the way identity can shift and expand as experiences grow. When Suresh shared stories of the ocean, I was back there too, holding the multitude of my identity alongside him. I asked Suresh to tell me more about his voyages: what was it like to be out in severe weather, to ride over enormous swells? Did he ever get seasick, and did his crew always get along? But Suresh did not want to swim into these perilous stories with me. Although he worked a difficult and physically taxing job, this is not what he wanted to focus on. Instead, he always came back to the beauty and vitality he felt at sea—what it was like to stare out at the vastness of the open ocean. He often closed his eyes and motioned with his hands as he spoke as if he was not confined to these hospital walls. Instead, he was swaying on the water feeling the lightness of physical freedom, and the way a body can move with such ease that it is barely perceptible, like water flowing over sand. The resonances of Suresh's stories contained both the power and challenges laden in this work. Although I sat at his bedside, healthy, my body too contained memories of freedom that in all likelihood will one day dissipate with age or illness. The question of how I will be seen, compared to how I hoped to be seen, lingered in my mind. Years ago, before going to medical school, I moved to Vail, Colorado. I worked four different jobs just to make ends meet, but making it work meant that on my days off, I was only a chairlift ride away from Vail's backcountry. I have a picture of this vigor in my mind—my snowboard carving into fresh powder, the utter silence of the wilderness at that altitude, and the way it felt to graze the powdery snow against my glove. My face was windburned, and my body was sore, but my heart had never felt so buoyant. While talking with Suresh, I could so vividly picture him as the robust man he once was, standing tall on the bow of his ship. I could feel the freedom and joy he described—it echoed in my own body. In that moment, the full weight of what Suresh had lost hit me as forcefully as a cresting wave—not just the physical decline, but the profound shift in his identity. What is more, we all live, myself included, so precariously at this threshold. In this work, it is impossible not to wonder: what will it be like when it is me? Will I be seen as someone who has lived a full life, who explored and adventured, or will my personhood be whittled down to my illness? How can I hold these questions and not be swallowed by them? "I know who you are now is not the person you've been," I said to Suresh. With that, he reached out for my hand and started to cry. We looked at each other with a new understanding. I saw Suresh—not just as a frail patient but as someone who lived a full life. As someone strong enough to cross the Atlantic for decades. In that moment, I was reminded of the Polish poet, Wislawa Szymborska's words, "As far as you've come, can't be undone." This, I believe, is what it means to honor the dignity of our patients, to reflect back the person they are despite or alongside their illness…all of their parts that can't be undone. Sometimes, this occurs because we see our own personhood reflected in theirs and theirs in ours. Sometimes, to protect ourselves, we shield ourselves from this echo. Other times, this resonance becomes the most beautiful and meaningful part of our work. It has been years now since I took care of Suresh. When the weather is nice, my wife and I like to take our young son to the harbor in South Boston to watch the planes take off and the barges leave the shore, loaded with colorful metal containers. We usually pack a picnic and sit in the trunk as enormous planes fly overhead and tugboats work to bring large ships out to the open water. Once, as a container ship was leaving the port, we waved so furiously at those working on board that they all started to wave back, and the captain honked the ships booming horn. Every single time we are there, I think of Suresh, and I picture him sailing out on thewaves—as free as he will ever be. Mikkael Sekeres: Welcome back to JCO's Cancer Stories: The Art of Oncology. This ASCO podcast features intimate narratives and perspectives from authors exploring their experiences in oncology. I'm your host, Mikkael Sekeres. I'm Professor of Medicine and Chief of the Division of Hematology at the Sylvester Comprehensive Cancer Center, University of Miami. What a treat we have today. We're joined by Dr. Alexis Drutchas, a Palliative Care Physician and the Director of the Core Communication Program at the Dana-Farber Cancer Institute, and Assistant Professor of Medicine at Harvard Medical School to discuss her article, "The Man at the Bow." Alexis, thank you so much for contributing to Journal of Clinical Oncology and for joining us to discuss your article. Dr. Alexis Drutchas: Thank you. I'm thrilled and excited to be here. Mikkael Sekeres: I wonder if we can start by asking you about yourself. Where are you from, and can you walk us a bit through your career? Dr. Alexis Drutchas: The easiest way to say it would be that I'm from the Detroit area. My dad worked in automotive car parts and so we moved around a lot when I was growing up. I was born in Michigan, then we moved to Japan, then back to Michigan, then to Hong Kong, then back to Michigan. Then I spent my undergrad years in Wisconsin and moved out to Colorado to teach snowboarding before medical school, and then ended up back in Michigan for that, and then on the east coast at Brown for my family medicine training, and then in Boston for work and training. So, I definitely have a more global experience in my background, but also very Midwestern at heart as well. In terms of my professional career trajectory, I trained in family medicine because I really loved taking care of the whole person. I love taking care of kids and adults, and I loved OB, and at the time I felt like it was impossible to choose which one I wanted to pursue the most, and so family medicine was a great fit. And at the core of that, there's just so much advocacy and social justice work, especially in the community health centers where many family medicine residents train. During that time, I got very interested in LGBTQ healthcare and founded the Rhode Island Trans Health Conference, which led me to work as a PCP at Fenway Health in Boston after that. And so I worked there for many years. And then through a course of being a hospitalist at BI during that work, I worked with many patients with serious illness, making decisions about discontinuing dialysis, about pursuing hospice care in the setting of ILD. I also had a significant amount of family illness and started to recognize this underlying interest I had always had in palliative care, but I think was a bit scared to pursue. But those really kind of tipped me over to say I really wanted to access a different level of communication skills and be able to really go into depth with patients in a way I just didn't feel like I had the language for. And so I applied to the Harvard Palliative Care Fellowship and luckily and with so much gratitude got in years ago, and so trained in palliative care and stayed at MGH after that. So my Dana-Farber position is newer for me and I'm very excited about it. Mikkael Sekeres: Sounds like you've had an amazing career already and you're just getting started on it. I grew up in tiny little Rhode Island and, you know, we would joke you have to pack an overnight bag if you travel more than 45 minutes. So, our boundaries were much tighter than yours. What was it like growing up where you're going from the Midwest to Asia, back to the Midwest, you wind up settling on the east coast? You must have an incredible worldly view on how people live and how they view their health. Dr. Alexis Drutchas: I think you just named much of the sides of it. I think I realize now, in looking back, that in many ways it was living two lives, because at the time it was rare from where we lived in the Detroit area in terms of the other kids around us to move overseas. And so it really did feel like that part of me and my family that during the summers we would have home leave tickets and my parents would often turn them in to just travel since we didn't really have a home base to come back to. And so it did give me an incredible global perspective and a sense of all the ways in which people develop community, access healthcare, and live. And then coming back to the Midwest, not to say that it's not cosmopolitan or diverse in its own way, but it was very different, especially in the 80s and 90s to come back to the Midwest. So it did feel like I carried these two lenses in the world, and it's been incredibly meaningful over time to meet other friends and adults and patients who have lived these other lives as well. I think for me those are some of my most connecting friendships and experiences with patients for people who have had a similar experience in living with sort of a duality in their everyday lives with that. Mikkael Sekeres: You know, you write about the main character of your essay, Suresh, who's a barge captain, and you mention in the essay that your family crossed the Atlantic on cargo ships four times when you were growing up. What was that experience like? How much of it do you remember? Dr. Alexis Drutchas: Our house, like our things, crossed the Atlantic four times on barge ships such as his. We didn't, I mean we crossed on airplanes. Mikkael Sekeres: Oh, okay, okay. Dr. Alexis Drutchas: We flew over many times, but every single thing we owned got packed up into containers on large trucks in our house and were brought over to ports to be sent over. So, I'm not sure how they do it now, but at the time that's sort of how we moved, and we would often go live in a hotel or a furnished apartment for the month's wait of all of our house to get there, which felt also like a surreal experience in that, you know, you're in a totally different country and then have these creature comforts of your bedroom back in Metro Detroit. And I remember thinking a lot about who was crossing over with all of that stuff and where was it going, and who else was moving, and that was pretty incredible. And when I met Suresh, just thinking about the fact that at some point our home could have been on his ship was a really fun connection in my mind to make, just given where he always traveled in his work. Mikkael Sekeres: It's really neat. I remember when we moved from the east coast also to the Midwest, I was in Cleveland for 18 years. The very first thing we did was mark which of the boxes had the kids' toys in it, because that of course was the first one we let them close it up and then we let them open it as soon as we arrived. Did your family do something like that as well so that you can, you know, immediately feel an attachment to your stuff when they arrived? Dr. Alexis Drutchas: Yeah, I remember what felt most important to our mom was our bedrooms. I don't remember the toys. I remember sort of our comforters and our pillowcases and things like that, yeah, being opened and it feeling really settling to think, "Okay, you know, we're in a completely different place and country away from most everything we know, but our bedroom is the same." That always felt like a really important point that she made to make home feel like home again in a new place. Mikkael Sekeres: Yeah, yeah. One of the sentences you wrote in your essay really caught my eye. You wrote about when you were younger and say, "I loved those times, the wild abandon of travel, the freedom of being somewhere new, the way identity can shift and expand as experiences grow." It's a lovely sentiment. Do you think those are emotions that we experience only as children, or can they continue through adulthood? And if they can, how do we make that happen, that sense of excitement and experience? Dr. Alexis Drutchas: I think that's such a good question and one I honestly think about a lot. I think that we can access those all the time. There's something about the newness of travel and moving, you know, I have a 3-year-old right now, and so I think many parents would connect to that sense that there is wonderment around being with someone experiencing something for the first time. Even watching my son, Oliver, see a plane take off for the first time felt joyous in a completely new way, that even makes me smile a lot now. But I think what is such a great connection here is when something is new, our eyes are so open to it. You know, we're constantly witnessing and observing and are excited about that. And I think the connection that I've realized is important for me in my work and also in just life in general to hold on to that wonderment is that idea of sort of witnessing or having a writer's eye, many would call it, in that you're keeping your eye open for the small beautiful things. Often with travel, you might be eating ramen. It might not be the first time you're eating it, but you're eating it for the first time in Tokyo, and it's the first time you've had this particular ingredient on it, and then you remember that. But there's something that we're attuned to in those moments, like the difference or the taste, that makes it special and we hold on to it. And I think about that a lot as a writer, but also in patient care and having my son with my wife, it's what are the special small moments to hold on to and allowing them to be new and beautiful, even if they're not as large as moving across the country or flying to Rome or whichever. I think there are ways that that excitement can still be alive if we attune ourselves to some of the more beautiful small moments around us. Mikkael Sekeres: And how do we do that as doctors? We're trained to go into a room and there's almost a formula for how we approach patients. But how do you open your mind in that way to that sense of wonderment and discovery with the person you're sitting across from, and it doesn't necessarily have to be medical? One of the true treats of what we do is we get to meet people from all backgrounds and all walks of life, and we have the opportunity to explore their lives as part of our interaction. Dr. Alexis Drutchas: Yeah, I think that is such a great question. And I would love to hear your thoughts on this too. I think for me in that sentence that you mentioned, sitting at that table with sort of people in the Navy from all over the world, I was that person to them in the room, too. There was some identity there that I brought to the table that was different than just being a kid in school or something like that. To answer your question, I wonder if so much of the challenge is actually allowing ourselves to bring ourselves into the room, because so much of the formula is, you know, we have these white coats on, we have learners, we want to do it right, we want to give excellent care. There's there's so many sort of guards I think that we put up to make sure that we're asking the right questions, we don't want to miss anything, we don't want to say the wrong thing, and all of that is true. And at the same time, I find that when I actually allow myself into the room, that is when it is the most special. And that doesn't mean that there's complete countertransference or it's so permeable that it's not in service of the patient. It just means that I think when we allow bits of our own selves to come in, it really does allow for new connections to form, and then we are able to learn about our patients more, too. With every patient, I think often we're called in for goals of care or symptom management, and of course I prioritize that, but when I can, I usually just try to ask a more open-ended question, like, "Tell me about life before you came to the hospital or before you were diagnosed. What do you love to do? What did you do for work?" Or if it's someone's family member who is ill, I'll ask the kids or family in the room, "Like, what kind of mom was she? You know, what special memory you had?" Just, I get really curious when there's time to really understand the person. And I know that that's not at all new language. Of course, we're always trying to understand the person, but I just often think understanding them is couched within their illness. And I'm often very curious about how we can just get to know them as people, and how humanizing ourselves to them helps humanize them to us, and that back and forth I think is like really lovely and wonderful and allows things to come up that were totally unexpected, and those are usually the special moments that you come home with and want to tell your family about or want to process and think about. What about you? How do you think about that question? Mikkael Sekeres: Well, it's interesting you ask. I like to do projects around the house. I hate to say this out loud because of course one day I'll do something terrible and everyone will remember this podcast, but I fancy myself an amateur electrician and plumber and carpenter and do these sorts of projects. So I go into interactions with patients wanting to learn about their lives and how they live their lives to see what I can pick up on as well, how I can take something out of that interaction and actually use it practically. My father-in-law has this phrase he always says to me when a worker comes to your house, he goes, he says to me, "Remember to steal with your eyes." Right? Watch what they do, learn how they fix something so you can fix it yourself and you don't have to call them next time. So, for me it's kind of fun to hear how people have lived their lives both within their professions, and when I practiced medicine in Cleveland, there were a lot of farmers and factory workers I saw. So I learned a lot about how things are made. But also about how they interact with their families, and I've learned a lot from people I've seen who were just terrific dads and terrific moms or siblings or spouses. And I've tried to take those nuggets away from those interactions. But I think you can only do it if you open yourself up and also allow yourself to see that person's humanity. And I wonder if I can quote you to you again from your essay. There's another part that I just loved, and it's about how you write about how a person's identity changes when they become a patient. You write, "And in that moment the full weight of what he had lost hit me as forcefully as a cresting wave. Not just the physical decline, but the profound shift in identity. What is more, we all live, me included, so precariously at this threshold. In this work, it's impossible not to wonder, what will it be like when it's me? Will I be seen as someone who's lived many lives, or whittled down only to someone who's sick?" Can you talk a little bit more about that? Have you been a patient whose identity has changed without asking you to reveal too much? Or what about your identity as a doctor? Is that something we have to undo a little bit when we walk in the room with the stethoscope or wearing a white coat? Dr. Alexis Drutchas: That was really powerful to hear you read that back to me. So, thank you. Yeah, I think my answer here can't be separated from the illness I faced with my family. And I think this unanimously filters into the way in which I see every patient because I really do think about the patient's dignity and the way medicine generally, not always, really does strip them of that and makes them the patient. Even the way we write about "the patient said this," "the patient said that," "the patient refused." So I generally very much try to have a one-liner like, "Suresh is a X-year-old man who's a barge captain from X, Y, and Z and is a loving father with a," you know, "period. He comes to the hospital with X, Y, and Z." So I always try to do that and humanize patients. I always try to write their name rather than just "patient." I can't separate that out from my experience with my family. My sister six years ago now went into sudden heart failure after having a spontaneous coronary artery dissection, and so immediately within minutes she was in the cath lab at 35 years old, coding three times and came out sort of with an Impella and intubated, and very much, you know, all of a sudden went from my sister who had just been traveling in Mexico to a patient in the CCU. And I remember desperately wanting her team to see who she was, like see the person that we loved, that was fighting for her life, see how much her life meant to us. And that's not to say that they weren't giving her great care, but there was something so important to me in wanting them to see how much we wanted her to live, you know, and who she was. It felt like there's some important core to me there. We brought pictures in, we talked about what she was living for. It felt really important. And I can't separate that out from the way in which I see patients now or I feel in my own way in a certain way what it is to lose yourself, to lose the ability to be a Captain of the ship, to lose the ability to do electric work around the house. So much of our identity is wrapped up in our professions and our craft. And I think for me that has really become forefront in the work of palliative care and in and in the teaching I do and in the writing I do is how to really bring them forefront and not feel like in doing that we're losing our ability to remain objective or solid in our own professional identities as clinicians and physicians. Mikkael Sekeres: Well, I think that's a beautiful place to end here. I can only imagine what an outstanding physician and caregiver you are also based on your writing and how you speak about it. You just genuinely come across as caring about your patients and your family and the people you have interactions with and getting to know them as people. It has been again such a treat to have Dr. Alexis Drutchas here. She is Director of the Core Communication Program at Dana-Farber Cancer Institute and Assistant Professor of Medicine at Harvard Medical School to discuss her article, "The Man at the Bow." Alexis, thank you so much for joining us. Dr. Alexis Drutchas: Thank you. This has been a real joy. Mikkael Sekeres: If you've enjoyed this episode, consider sharing it with a friend or colleague, or leave us a review. Your feedback and support helps us continue to save these important conversations. If you're looking for more episodes and context, follow our show on Apple, Spotify, or wherever you listen, and explore more from ASCO at ASCO.org/podcasts. Until next time, this has been Mikkael Sekeres for the ASCO podcast Cancer Stories: The Art of Oncology. The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions. Guests on this podcast express their own opinions, experience, and conclusions. Guest statements on the podcast do not express the opinions of ASCO. The mention of any product, service, organization, activity, or therapy should not be construed as an ASCO endorsement. Show notes: Like, share and subscribe so you never miss an episode and leave a rating or review. Guest Bio: Dr. Alexis Drutchas is a palliative care physician at Dana Farber Cancer Institute.
O anúncio foi formalizado no fim‑de‑semana: UGT e CGTP vão promover uma greve geral, a primeira em 12 anos, contra a reforma laboral em curso. O primeiro-ministro, esse, disparou contra o PCP e PS, que acusou de estarem por detrás do anúncio. Mas o que está por trás desta frente, a primeira rutura da AD com os sindicatos? E quais são os prós e contras desta guerra, do lado do Executivo? A jornalista Cátia Mateus explica, os jornalistas Paula Caeiro Varela, Liliana Valente e Vítor Matos analisam, sob moderação de David Dinis. Este episódio tem sonoplastia de Salomé Rita e ilustração de Carlos Paes (com apoio de IA).See omnystudio.com/listener for privacy information.
Há dez anos começavam os dias da geringonça. A 10 de Novembro, o governo chefiado por Passos Coelho caía enquanto PS, PE e PCP firmavam os acordos que permitiriam aos socialistas governar.See omnystudio.com/listener for privacy information.
Há dez anos começava a geringonça: caía o governo de Passos Coelho e BE e PCP davam ao PS o apoio que permitiria aos socialistas governar. Em 2025 o que sobra da geringonça?See omnystudio.com/listener for privacy information.
Explore how GLP-1 meds can help or harm eating disorders with Dr. Laura Bridge When weight-loss meds meet eating disorders: GLP-1 drugs are reshaping medicine, but could they also be fueling disordered eating? Join Dr. Laura Bridge as we unpack the risks, red flags, and how to keep “healthy” from turning harmful. Also, how to approach restrictive eating disorders, bulimia, and binge eating disorder as a PCP. Claim CME for this episode at curbsiders.vcuhealth.org! Patreon | Episodes | Subscribe | Spotify | YouTube | Newsletter | Contact | Swag! | CME Show Segments Introduction Defining Eating Disorders Screening & Permission to Discuss Clinical Approach & History Gathering Treatment Framework GLP-1 Contraindications Dr. Bridge's Take-Home Points Credits Producer, writer, show notes, cover art and infographics: Isabel Valdez, PA-C Hosts: Matthew Watto MD, FACP; Paul Williams MD, FACP Reviewer: Molly Heublein MD Showrunners: Matthew Watto MD, FACP; Paul Williams MD, FACP Technical Production: PodPaste Guest: Laura Bridge MD, FACP Disclosures Dr. Laura Bridge no relevant financial disclosures. The Curbsiders report no relevant financial disclosures. Sponsor: Locumstory Learn about locums and get insights from real-life physicians, PAs and NPs at Locumstory.com. Sponsor: Panacea Legal Panacea Legal is giving Curbsiders listeners one more reason to feel thankful with 50% off any contract review service by using promo code CURB50. But hurry, this offer is only available for the first 10 doctors who use the code. Visit Panacea.Legal today Sponsor: Hydrow Head over to Hydrow.com and use code CURB to save up to $600 off on Hydrow rower during this holiday season. Sponsor: Grammarly Visit Grammarly.com/podcast and Sign up for FREE
Dr. Pedro Barata and Dr. Aditya Bagrodia discuss the evolving landscape of testicular cancer survivorship, the impact of treatment-related complications, and management strategies to optimize long-term outcomes and quality of life. TRANSCRIPT: Dr. Pedro Barata: Hello and welcome to By the Book, a podcast series from ASCO that features engaging conversations between editors and authors of the ASCO Educational Book. I'm Dr. Pedro Barata. I'm a medical oncologist at University Hospitals Seidman Cancer Center and associate professor of medicine at Case Western Reserve University in Cleveland, Ohio. I'm also an associate editor of the ASCO Educational Book. We all know that testicular cancer is a rare but highly curable malignancy that mainly affects young men. Multimodal advances in therapy have resulted in excellent cancer specific survival, but testicular cancer survivors face significant long term treatment related toxicities which affect their quality of life and require surveillance and management. With that, I'm very happy today to be joined by Dr. Aditya Bagrodia, a urologic oncologist, professor, and the GU Disease Team lead at UC San Diego[KI1] Health, and also the lead author of the recently published paper in the ASCO Educational Book titled, "Key Updates in Testicular Cancer: Optimizing Survivorship and Survival." And he's also the host of the world-renowned BackTable Urology Podcast. Dr. Bagrodia, I'm so happy that you're joining us today. Welcome. Dr. Aditya Bagrodia: Thanks, Pedro. Absolutely a pleasure to be here. Really appreciate the opportunity. Dr. Pedro Barata: Absolutely. So, just to say that our full disclosures are available in the transcript of this episode. Let's get things started. I'm really excited to talk about this. I'm biased, I do treat testicular cancer among other GU malignancies and so it's a really, really important topic that we face every day, right? Fortunately, for most of these patients, we're able to cure them. But it always comes up the question, "What now? You know, scans, management, cardio oncology, what survivorship programs we have in place? Are we addressing the different survivorship piece, psychology, fertility, et cetera?" So, we'll try to capture all of that today. Aditya, congrats again, you did a fantastic job putting together the insights and thoughts and what we know today about this important topic. And so, let's get focused specifically about what happens when patients get cured. So, many of us, in many centers, were fortunate enough to have these survivorship programs together, but I find that sometimes from talking to colleagues, they're not exactly the same thing and they don't mean the same thing to different people, to different institutions, right? So, first things first. What do you tell a patient perhaps when they ask you, "What can happen to me now that I'm done with treatment for testicular cancer?" Whether it's chemotherapy or just surgery or even radiation therapy? "So, what about the long term? What should I expect, Doctor, that might happen to me in the long run?" Dr. Aditya Bagrodia: Totally. I mean, I think that question's really front and center, Pedro, and really appreciate you all highlighting this topic. It was an absolute honor to work with true thought leaders and the survivorship bit of it is front and center, in my opinion. It's really the focus, you know, we, generally speaking should be able to cure these young men, but it's the 10, 15, 20 years down the way that they're going to largely contend with. The conversation really begins at diagnosis, pre-education. Fortunately, the bulk of patients that present are those with stage one disease, and even very basic things like before orchiectomy, talking about a prosthetic; we know that that can impact body image and self esteem, whether or not they decide to receive it or not. Actually, just being offered a prosthetic is important and this is something, you know, for any urologist, it's kind of critical. To discussing fertility elements to this, taking your time to examine the contralateral testicle, ask about fertility problems, issues, concerns, offer sperm banking, even in the context of a completely normal contralateral testicle, I think these things are quite important. So if it's somebody with stage one disease, you know, without going too far down discussing adjuvant therapy and so forth, I will start the conversation with, "You know, the testes do largely two things. They make testosterone and they make sperm." By and large, patients are going to be able to have acceptable levels of testosterone, adequate sperm parameters to maintain kind of a normal gonadal state and to naturally conceive, should that be something they're interested in. However, there's still going to be, depending on what resource you look at, somewhere in the order of 10-30% that are going to have issues. Where I think for the stage one patients, it's really incumbent upon us is actually to not wait for them to discuss their concerns, particularly with testosterone, which many times can be a little bit vague, but to proactively ask about it every time. Libido, erectile quality, muscle mass maintenance, energy, fatigue. All of these are kind of associated symptoms of hypogonadism. But for a lot of kids 18-20 years old, it's going to be something insidious that they don't think about. So, for the stage one patients, it absolutely starts with gonadal function. If they are stage two getting surgery, I think the counseling really needs to center around a possibility for ejaculatory dysfunction. Now, for a chemotherapy-naive, nerve-sparing RPLND, generally these days we should be able to preserve ejaculatory function at high volume centers, but you still want to bring that up and again kind of touch base on thinking about sperm banking and so forth before the operation, scars, those are things I think worth talking about, small risk of ascites. Then, I think the intensity of potential long term adverse effects really ramps up when we're talking about systemic therapy, chemotherapy. And then there's of course some radiation therapy specific elements that come up. So, for the chemotherapy bits of it, I really think this is going to be something that can be a complete multi-system affected intervention. So, anxiety, depression, our group has actually shown using some population resources that even suicidality can be increased among patients that have been treated for germ cell tumor. You know, really from the top down, tinnitus, hearing changes, those are things that we need to ask about at every appointment. Neuropathy, sexual health, that we kind of talked about, including ED (erectile dysfunction), vertigo, dizziness, Raynaud's phenomenon, these are kind of more the symptoms that I think we need to inquire about every time. And what we do here and I think at a lot of survivorship programs is use kind of a battery of validated instruments, germ cell tumor specific, platinum treated patient specific. So we use a combination of EORTC questions and PROMIS questions, which actually serves as like a review of systems for the patient, also as a research element. We review that and then depending on what might be going on, we can dig into that further, get them over to colleagues in audiology or psychology, et cetera. And then of course, screening for the hypertension, hyperlipidemia, metabolic syndrome with basically you or myself or somebody kind of like us serving, many times it's the role of the PCP, just making sure we're checking out, you know, CBC, CMP, et cetera, lipid parameters to screen for those kind of cardiac associated issues along with secondary malignancies. Dr. Pedro Barata: So that's super comprehensive and thorough. Thank you so much. Actually, I love how you break it down in a simple way. Two functions of the testes, produce testosterone and then, you know, the problem related to that is the hypogonadism, and then the second, as you mentioned, produce sperm and of course related to the fertility issues with that. So, let's start with the first one that you mentioned. So, you do cite that in your paper, around 5-10% of men end up getting, developing hypogonadism, maybe clinical when they present with symptoms, maybe subclinical. So, I'm wondering, for our audience, what kind of recommendations we would give for addressing that or kind of thinking of that? How often are you ordering those tests? And then, when you're thinking about testosterone replacement therapy, is that something you do immediately or are there any guidelines into context that? How do you approach that? Dr. Aditya Bagrodia: So, just a bit more on digging into it even in terms of the questions to ask, you know, "Do you have any decrease in sexual drive? Any erectile dysfunction? Are your morning erections still taking place? Has the ejaculate volume changed? Physically, muscle mass, strength? Have you been putting on weight? Have you noticed increase in body fat?" And sometimes this is complicated because there's some anxiety that comes along with a cancer diagnosis when you're 20, 30 years old, multifactorial, hair loss, hot flashes, irritability. Sometimes they'll, you know, literally they'll say, "You know, my significant other or partners noticed that I'm really just a little bit labile." So I think, you know, there's the symptoms and then checking, usually kind of a gonadal panel, FSH, LH, free and total testosterone, sex hormone binding globulin, that's going to be typically pretty comprehensive. So if you've got symptoms plus some laboratory work, and ideally that pre-orchiectomy testosterone gives you some delta. If they started out at an 800, 900, now they're 400, that might be a big change for them. And then, when you talk about TRT (Testosterone Replacement Therapy) recommendations, you know, Pedro, yourself, myself, we're kind of lucky to be at academic centers and we've got men's health colleagues that are ultra experts, but at a high level, I would say that a lot of the TRT options center around fertility goals. Exogenous testosterone treats the low T, but it does suppress gonadal function, including spermatogenesis. So if that's not a priority, they can just get TRT. It should be done under the care of a urologist, a men's health, an endocrinologist, where we're checking liver chemistries and CBCs and a PSA and so forth. If they're interested in fertility preservation, then I would say engaging an endocrinologist, men's health expert is important. There's medications even like hCG, Clomid, which works centrally and stimulate the gonadal access. Niche scenarios where they might want standard TRT now, and then down the way, 5, 7 years, they're thinking about coming off of that for fertility purposes, I think that's really where you want to have an expert involved because there's quite a bit of nuance there in recovery of actual spermatogenesis and so forth. To kind of summarize, you got to ask about it. Checking it is, is not overly complicated. We do a baseline pre-orchiectomy and at least once annually, you can tag it in with the tumor markers, so it's not an extra blood draw. And if they have symptoms of course, kind of developed, then we'll move that up in the evaluation. Dr. Pedro Barata: Got it. And you also touch base on the fertility angle, which is truly important. And I'm just curious, you know, a lot of times many of us might see one, two patients a year, right, and we forget these protocols and what we've got to do about that. And so I'm interested to hear your thoughts about when you think about fertility, and how proactive you get. In other words, who do you refer for the fertility clinic, for a fertility preservation program? You know, do all cases despite getting through orchiectomy or just the cases that you're going to, you know you're going to seek chemotherapy at some point? What kind of selection or it depends on the chemo, like how do you do that assessment about the referral for preservation program that you might have available at UCSD? Dr. Aditya Bagrodia: Yeah, I mean I feel really fortunate to sit on the NCCN Testis Cancer Guidelines. It's in there that fertility counseling should be discussed prior to orchiectomy. So 100% bring it up. If there are risk factors, undescended testicles, previous history of fertility concerns, atrophic contralateral testicle, anything on the ultrasound like microlithiasis in the contralateral testicle, you kind of wanna get it there. And then again, there's kind of niche scenarios where you're really worried, maybe get a semen analysis and it doesn't look that good, arrange for the time of orchiectomy to have onco-testicular sperm extraction from the, quote unquote, "normal" testis parenchyma. You know, I think you have to be kind of prepared to go that route and really make sure you're doing this completely comprehensively. So pre-orchiectomy all patients. Don't really push for it too hard if they've got a contralateral testicle, if they've had no issues having children. There's some cost associated with this, sperm banking still isn't kind of covered even in the context of men with cancer. If they've got risk factors, absolutely pre-orchiectomy. Pre-RPLND, even though the rates of ejaculatory dysfunction at a high-volume center should be low single digits, I'll still offer it. That'd be a real catastrophe if they were in that small proportion of patients and now they're going to be reliant on things like intrauterine insemination, where it becomes quite expensive. Pre-chemo, everybody. That's basically a standard these days where it should be discussed and it's kind of amazing currently, even if you don't have an accessible men's health fertility clinic, there are actually companies, I have no vested interest, Fellow is one such company where you can actually create an account, receive a FedEx semen analysis and cryopreservation kit, send it back in, and all CLIA certified, it's based out of California. The gentleman that runs it, is a urologist and very, very bright guy who's done a lot of great stuff for testis cancer. So, even for patients that are kind of in extremis at the hospital that kind of need to get going like yesterday, we still discuss it. We've got some mechanisms in place to either have them take a semen analysis over to our Men's Health clinic or send it off to Fellow, which I think is pretty cool and that even extends to some of our younger adolescent patients where going to a clinic and providing a sample might be tricky. So, I think bringing it up every stage, anytime there's an intervention that might be offered, orchiectomy, chemo, surgery, radiation, it's kind of incumbent on us to discuss it. Dr. Pedro Barata: Gotcha. That's super helpful. And you also touch base on another angle, which is the psychosocial angle around this. You mentioned suicidal rates, you mentioned anxiety, perhaps depression in some cases as well as chronic fatigue, not necessarily just because of the low testosterone that you can get, but also from a psychological perspective. I'm curious, what do the recommendations look like for that? Do these patients need to see a social worker or a psychologist, or do they need to answer a screening test every time they come to see us and then based on that, we kind of escalate, take the next steps according to that? Do they see a psychologist perhaps every so often? How should that be managed and addressed? Dr. Aditya Bagrodia: It's an excellent question and again, these can be rather insidious symptoms where if you don't really dig in and inquire, they can be glossed over. I mean, how easy to say, "Your markers look okay, your scans look okay. See you in six months," and keep it kind of brief. First off, I think bringing it up proactively and normalizing it, that, "This may be something that you experience. Many people do, you're not alone, there's nothing kind of wrong with you." I also think that this is an area where support groups can be incredibly useful. We host the Testicular Cancer Awareness Foundation support group here. They'll talk about chemo brain or just like a little bit of an adjustment disorder after their diagnosis. Support groups, I think are critical. As I mentioned, we have a survivorship program that's led by a combination of our med oncs, myself on the uro-onc side, as well as APPs, where we are systematically asking about essentially the whole litany of issues that may arise, including psychosocial, anxiety, depression, suicidality. And we've got a nice kind of fast path into our cancer center support services for these young men to meet with a psychologist. If that isn't going to be sufficient, they can actually see a psychiatrist to discuss medications and so forth. I do think that we've got to screen for these because, as anticipated from diagnosis, those first 2 years, we see a rise. But even 10, 15 years out, we note, compared to controls, that there is an increased level of anxiety, depression, suicidality that might not just take place at that initial acute period of diagnosis and treatment. Dr. Pedro Barata: Really well said. Super important. So I guess if I were to put all these together, with these really amazing advances in technology, we all know AI, some of us might be more or less aware of biomarkers coming up, including microRNA for example, and others, like as I think of all these potential long term complications for these patients, look at the future, I guess, can we use this as a way to deescalate treatment where it's not really necessary, as a way to actually prevent some of these complications? Like, how do we see where we're heading? As we manage testicular cancer, let's say, within the next 5 or 10 years, do you think there's something coming up that's going to be different from what we're doing things today? Dr. Aditya Bagrodia: Totally. I mean, I think it's as exciting as a time as there's ever been, you know, maybe notwithstanding circa 1970s when platinum was discovered. So microRNAs, which you mentioned, you know, there's a new candidate biomarker, microRNA-371. We are super excited here at UCSD. We actually have it CLIA-certified available in our lab and are ordering these tests for patients kind of in their acute stage, you know, stage one and surveillance, stage two, post-RPLND, receiving chemotherapy. And essentially this is a universal germ cell tumor specific biomarker, except for teratoma, suffice it to say 90% sensitive and specific. And I think it's going to change the way that we diagnose and manage patients. You know, pre-orchiectomy, that's pretty straightforward. Post-orchiectomy, maybe we can really decrease the number of CT scans that are done. Maybe we can identify those patients that basically have occult disease where we can intervene early, either with RPLND or single cycle chemo. Post-RPLND, identify the patients who are at higher risk of relapse that may benefit from some adjuvant therapy. In the advanced setting, look at marker decline for patients in addition to standard tumor markers. Can we modulate their systemic therapy? So, the international interest is largely on modifying things. There's really cool clinical trials that we have for stage one patients, that treatment would be prescribed based on a post-orchiectomy microRNA. I think the microRNAs are really exciting. Teratoma remains an outstanding question. I think this is where maybe ctDNA, perhaps some radiomics and advanced imaging processing and incorporating AI may allow us to safely avoid a lot of these post-chemo RPLNDs. And then identification using SNPs and so forth of who might be most susceptible to some of the cardiac toxicity, autotoxicity and personalizing things in that way as well. Dr. Pedro Barata: Super exciting, right, what's about to come? And I agree with you, I think it's going to change dramatically how we manage this disease. This has been a pleasure sitting down with you. I guess before letting you go, anything else you'd like to add before we wrap it up? Dr. Aditya Bagrodia: Yeah, first off, again, just want to thank you and ASCO for the opportunity. And it's easy enough to, I think, approach a patient with the testicular germ cell tumor as, "This is an easy case. We're just going to do whatever we've done. Go to the guidelines that says do X, Y, or Z." But there's so much more nuance to it than that. Getting it done perfectly, I think, is mandatory. Whatever we do is an impact on them for the next 50, 60, 70 years of their life. And I found the germ cell tumor community, people are really passionate about it. If you're ever uncertain, there's experts throughout the country and internationally. Ask somebody before you do something that you can't undo. I think we owe it to them to get it perfect so that we can really maximize the survivorship and the survival like we've been talking about. Dr. Pedro Barata: Aditya, thanks for sharing your fantastic insights with us on this podcast. Dr. Aditya Bagrodia: All right, Pedro. Fantastic. Appreciate the opportunity. Dr. Pedro Barata: And also, thank you to our listeners for your time today. I actually encourage you to check out Dr. Bagrodia's article in the 2025 ASCO Educational Book. We'll post a link to the paper in the show notes. Remember, it's free access online, and you can actually download it as well as a PDF. You can also find on the website a wealth of other great papers from the ASCO Educational Book on key advances and novel approaches that are shaping modern oncology. So with that, thank you everyone. Thank you, Aditya, one more time, for joining us. Thank you, have a good day. Disclaimer: The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions. Guests on this podcast express their own opinions, experience, and conclusions. Guest statements on the podcast do not express the opinions of ASCO. The mention of any product, service, organization, activity, or therapy should not be construed as an ASCO endorsement. Follow today's speakers: Dr. Pedro Barata @PBarataMD Dr. Aditya Bagrodia @AdityaBagrodia Follow ASCO on social media: @ASCO on X (formerly Twitter) ASCO on Bluesky ASCO on Facebook ASCO on LinkedIn Disclosures: Dr. Pedro Barata: Stock and Other Ownership Interests: Luminate Medical Honoraria: UroToday Consulting or Advisory Role: Bayer, BMS, Pfizer, EMD Serono, Eisai, Caris Life Sciences, AstraZeneca, Exelixis, AVEO, Merck, Ipson, Astellas Medivation, Novartis, Dendreon Speakers' Bureau: AstraZeneca, Merck, Caris Life Sciences, Bayer, Pfizer/Astellas Research Funding (Inst.): Exelixis, Blue Earth, AVEO, Pfizer, Merck Dr. Aditya Bagrodia: Consulting or Advisory Role: Veracyte, Ferring
TITANIC A young aristocratic woman named Rose, suffocating in a rigid engagement, falls for free-spirited third-class passenger Jack Dawson aboard the unsinkable ocean liner - Titanic. Their secret romance defies class and her possessive fiancé as the ship sails toward disaster. When it hits an iceberg, their struggle to survive reveals love, sacrifice, and the brutal divide between those rescued and those left behind. Craig, Elisabeth and guest Ryley Brown talk about touchstone cinema, historical fiction, PCP chowder and the movie “Titanic” on this week's Matinee Heroes. Show Notes 1:20 Craig, Elisabeth and Ryley Brown talk about boats. 7:37 Craig, Elisabeth and Ryley discuss "Titanic" 1:08:03 Recasting 1:44:36 Double Feature 1:47:42 Final Thoughts 1:56:31 A preview of next week's episode "Ben-Hur" Our next no-ender is the biblical fiction "Ben-Hur"
Dave and Cody dive deep into House of Dynamite, Kathryn Bigelow's nail-biting new nuclear thriller that's equal parts technical masterpiece and moral Rorschach test. Is it brilliant minimalism—or a cinematic blue screen of death?They also break down the possible sale of Warner Bros. Discovery, what it could mean for movie theaters, and whether James Gunn's fledgling DCU survives a Netflix takeover.It's the perfect PCP blend of wit, wonder, and way-too-much coffee.Cold Open: Dave overshares at the coffee drive-thru ☕Pop Culture News:Why Warner Bros. might be up for saleThe Netflix wildcard and the ripple effect on theatersThe DCU's uncertain future under Gunn & SafranMain Review: House of DynamiteMultiple perspectives, one moral bombThe power of restraint vs. reactionIdris Elba's presidential gravitasWhat works, what fizzles, and why the ending divides everyoneWinner & Loser of the MovieThe Lobby Q&A
Flu season - 1:44 Flu and when to go to the PCP - 1:57 Parenting tip - 8:05 Trivia segment - 9:05 Conclusion - 9:18
Discover why establishing a relationship with a primary care doctor is one of the most important investments in your long-term health. From preventative screenings to managing chronic conditions, we break down what a PCP really does for you.For more, visit https://amanacareclinic.com/ Amana Care Clinic City: Davenport Address: 2162 W Kimberly Rd, Website: https://amanacareclinic.com/
Send us a textHello Fellow Airgun Geeks,The Airgun Geeks Podcast welcomes two of the biggest names in the airgun world—Chris “The Turret” Turek of Up North Airgunner and Officer PJ Clarke of The Wisconsin Airgunner!In this episode, we dive deep into: Chris's first place win at the 2025 Extreme Benchrest (EBR) competition The controversial topic of airgun modifications and how they affect manufacturer warranties The behind-the-scenes mindset of top-tier airgun competitors How far you can push your airgun without crossing the lineWhether you're a PCP shooter, benchrest competitor, or just love precision gear, this conversation is packed with insights, laughs, and pro-level advice.Support the show
Host Nate Kaufman brings Rich Helppie back for a discussion about healthcare access. A 30-day wait for a first oncology visit after hearing the word leukemia is not an edge case—it's the new normal in a system where demand outpaces supply and incentives reward the wrong behaviors. Nate opens with a personal story that reveals how access feels when the stakes are life and death, then pulls back the lens to explain why it happens: a 12-year training pipeline for specialists, uneven reimbursement that pushes clinicians toward concierge and direct primary care, and payer tactics that encourage consolidation rather than capacity.Kaufman and Helppie then get specific about the economics. Medicaid rates that barely cover overhead lead practices to cap panels, while insurers play separate groups against each other until they merge, gaining leverage but not necessarily improving availability. Primary care, which should function like a straightforward retail experience, is instead forced through insurance mechanics that add friction to simple, high-value services. The result is predictable: over 40 percent of ER visits come from Medicaid patients who couldn't access timely outpatient care, and the most vulnerable pay the highest price in avoidable emergencies.Their conversation wrestles with the big numbers and the real trade offs. Ten percent of patients drive more than 80 percent of spending across Medicare and commercial plans. Pharma's incentives to expand lifelong demand clash with insurers' incentives to deny care. The federal government, the largest health benefits organization in the world, changes leadership every few years, making long-term workforce planning and access expansion difficult. They outline pragmatic moves that can help now: secure continuity with direct primary care or concierge if possible, build a relationship with a PCP who can open specialist doors, and for complex care, shop outcomes rather than prices.If you've felt the squeeze—months-long waits, denials, or a scramble for appointments—this conversation gives language, data, and practical options. Listen to understand why access is collapsing, what levers could ease the pressure, and how to protect your path to timely, high-quality care today. If the ideas resonate, follow and share, and leave a review with your own access story—what worked, what didn't, and what needs to change next.Support the showEngage the conversation on Substack at The Common Bridge!
O respeito pelos deputados do PCP: “Aquele senhor sofreu como eu não sofri”. A matança da Páscoa: “O primeiro exercício de guerra híbrida em Portugal”. O 25 de novembro. E ainda Sá Carneiro, Cunhal, Melo Antunes e Ramos Horta, vistos por Ângelo Correia.See omnystudio.com/listener for privacy information.
Pop Culture Pastor dives headfirst into the fog. Dave and Cody rewind Frank Darabont's soul-crusher The Mist (2007): why the human breakdown still hits, why Marcia Gay Harden steals the whole movie, and how that ending becomes a parable about quitting one step too soon. They riff on what holds up and what doesn't, then play the show's greatest hits: Muppet-ize the Movie, Which Character Would You Be? and the Winner & Loser of the movie (sorry, Stephen King… Darabont's ending wins).Plus: a spicy news bit on the “least attractive hobbies for men” list (video games, figurines, crypto, trolling, gambling) and why maybe the problem isn't hobbies—it's imbalance.Come for the monsters, stay for the meaning.Agree? Hate it with a white-hot passion? Sound off and tag the show.Subscribe, rate, and check the PCP swag in the Linktree— https://linktr.ee/PopCulturePastorPod
In this episode of the Atomic Anesthesia Podcast, we tackle the complex reality of caring for patients under the influence of drugs or alcohol, a frequent challenge for nurse anesthesia residents and CRNAs. Covering the physiological effects and anesthetic implications of acute and chronic intoxication with alcohol, benzodiazepines, hallucinogens (such as LSD, PCP, and MDMA), cocaine, and cannabinoids, this episode offers fast, practical guidance for optimizing perioperative care and minimizing patient risk. Listeners will learn how substance use alters anesthetic requirements, impacts drug metabolism, and poses unique airway and hemodynamic risks, while also receiving actionable tips for drug class-specific management like when to use or avoid certain agents, the importance of invasive monitoring, and strategies for handling withdrawal or overdose. Tune in for a high-yield rundown that will help you make safer decisions when handling intoxicated patients in the OR.Want to learn more? Create a FREE account at www.atomicanesthesia.com⚛️ CONNECT:
A Esquerda à esquerda do PS e o próprio PS vivem uma crise que se traduz numa perde eleitoral de quase 20 pontos percentuais e uma representação parlamentar que se reduziu a metade em apenas três anos. As autárquicas não serviram para aliviar a crise e o partido que mais perdeu, o BE, vai mudar de liderança. Por onde se começa a engordar novamente este campo politico? Pelos partidos à esquerda do PS ou pelo recentramento do Partido Socialista? São as lideranças que potenciam o momento de crise ou são os partidos colectivamente que deixaram de saber para quem estavam a falar? Perguntas à procura de respostas, numa conversa com Daniel Oliveira, colunista do Expresso e comentador da SIC.See omnystudio.com/listener for privacy information.
Neste episódio do Perguntar Não Ofende, Miguel Carvalho apresenta as principais conclusões do seu livro Por Dentro do Chega, a mais extensa investigação sobre a ascensão e os bastidores do partido liderado por André Ventura. O jornalista descreve um movimento político que se constrói em torno de um culto de personalidade e de uma lógica de poder pessoal, mais do que de uma ideologia estruturada. As vozes de ex-dirigentes, citadas no livro, revelam um ambiente de manipulação interna, gravações clandestinas, disputas de poder e ausência de transparência financeira. Carvalho analisa o crescimento eleitoral do Chega, que se torna a segunda força política portuguesa em apenas seis anos. Explica que o partido capta um eleitorado popular, maioritariamente vindo do PCP e do PSD, desiludido com o sistema e atraído por um discurso de protesto simples e emocional. Compara o fenómeno à transformação populista de outros países europeus, sublinhando que Ventura se adapta ao “ar do tempo” e domina as dinâmicas mediáticas e digitais com grande eficácia. O jornalista destaca ainda o papel das redes sociais, dos media sensacionalistas e de movimentos religiosos radicais na consolidação do partido. Denuncia a ausência de rastreio dos candidatos, a entrada de figuras com antecedentes criminais e a permeabilidade do Chega a grupos extremistas. Para Carvalho, o partido vive numa bolha de desinformação e paranoia, alimentada por uma estrutura centralizada e autoritária. Por fim, Miguel Carvalho reflete sobre o papel do jornalismo na vigilância democrática. Assume ter sentido pressões durante a investigação, mas defende que a missão do repórter é resistir ao medo e expor as contradições do poder.See omnystudio.com/listener for privacy information.
Na Vichyssoise, Ana Gomes defende que candidatos apoiados por BE, PCP e Livre devem desistir a favor de Seguro antes da primeira volta. Avalia negativamente desempenho nacional e europeu de Costa.See omnystudio.com/listener for privacy information.
Neste episódio do Perguntar Não Ofende, Miguel Carvalho apresenta as principais conclusões do seu livro Por Dentro do Chega, a mais extensa investigação sobre a ascensão e os bastidores do partido liderado por André Ventura. O jornalista descreve um movimento político que se constrói em torno de um culto de personalidade e de uma lógica de poder pessoal, mais do que de uma ideologia estruturada. As vozes de ex-dirigentes, citadas no livro, revelam um ambiente de manipulação interna, gravações clandestinas, disputas de poder e ausência de transparência financeira. Carvalho analisa o crescimento eleitoral do Chega, que se torna a segunda força política portuguesa em apenas seis anos. Explica que o partido capta um eleitorado popular, maioritariamente vindo do PCP e do PSD, desiludido com o sistema e atraído por um discurso de protesto simples e emocional. Compara o fenómeno à transformação populista de outros países europeus, sublinhando que Ventura se adapta ao “ar do tempo” e domina as dinâmicas mediáticas e digitais com grande eficácia. O jornalista destaca ainda o papel das redes sociais, dos media sensacionalistas e de movimentos religiosos radicais na consolidação do partido. Denuncia a ausência de rastreio dos candidatos, a entrada de figuras com antecedentes criminais e a permeabilidade do Chega a grupos extremistas. Para Carvalho, o partido vive numa bolha de desinformação e paranoia, alimentada por uma estrutura centralizada e autoritária. Por fim, Miguel Carvalho reflete sobre o papel do jornalismo na vigilância democrática. Assume ter sentido pressões durante a investigação, mas defende que a missão do repórter é resistir ao medo e expor as contradições do poder.See omnystudio.com/listener for privacy information.
In true form to the topic this reflection episode is rather playful between Nick and Billy as they explore how to play with kids. We discuss why it can be tough, how to target specific struggles, the role of educators and how play changes from kids to teens. As always there are beautiful reflections, questions and tips from the wonderful PCP community. Thank you as always and we hope you like it.
If you don't invest in your weaknesses now, they will haunt you down the road.This conversation originally aired on Episode 13 of Long Run Labs, my new podcast on the business of the outdoor industry.Alex is the Founder and CEO of Eternal. Before founding Eternal, Alex was the founder and CEO of The Athletic, a subscription sports media company founded in 2016. The Athletic reached 1M paid subscribers faster than any publishing company in history and sold to The New York Times in 2022 for $550M. Prior to The Athletic, Alex ran Product & Design for Strava, helping the platform go from 800 users to 10s of millions. Originally from Philadelphia, Alex lives in Presidio Heights with his wife, two kids, and golden retriever. Jon chats with Alex about:Alex's Journey as a Runner and Endurance AthleteBuilding Strava's Growth and CommunityThe Athletic's Creation and Success StoryFounding Eternal and Its MissionLeadership Philosophy and Team BuildingStay connected:Follow Alex:https://x.com/amatherhttps://www.linkedin.com/in/alexemather/This episode is supported by:Tifosi Optics: Fantastic sunglasses for every type of run. Anti-bounce fit, shatterproof, and scratch resistant. Get 20% off when you use this link!Janji: Use code “FTLR” at checkout when shopping at janji.com for 10% off your order and see why Janji is the go-to for runners who want performance gear made to explore. All apparel is backed by a 5 year guarantee, so you know it's meant to last!Eternal: Eternal is a performance health company for runners, endurance athletes, and anyone serious about their training. Eternal just added PCP capabilities for those in NY and CA to answer the question of, “so, does this mean you're my doctor?”PUMA: Get your pair at your local Fleet Feet or your favorite local running shop!AmazFit Check out the T-Rex 3 and a selection of GPS watches at amazfit.com and use code “FTLR” for 10% off.
Matt and Allie are back to discuss this month's clinical corner article! In this case presentation- you'll hear about a patient who experienced consistent gluteal pain even after seeing his PCP, PA and PT. With more and more time passing and worsening symptoms, and a palpable mass finding by the PT, the patient was urged to get an MRI. This uncovered that the mass was identified as advanced-stage non-Hodgkin's lymphoma. Luckily, after treatment and a couple months of PT, the patient resumed walking, golfing, etc with no pain and in complete remission! This article highlights the importance of hands-on PT, self advocacy, and early intervention.Read the article here: https://www.jospt.org/doi/10.2519/josptcases.2025.0126https://www.jospt.org/doi/10.2519/josptcases.2025.0126Did you know that you don't need a doctor's prescription to receive physical therapy? The laws of Direct Access allow you to receive physical therapy without a referral and still use your insurance benefits! Learn more on how Direct Access can help YOU! Our website: https://www.oxfordphysicaltherapy.com/
Tune in to listen as expert faculty, Dr Christopher L. Bowlus and Dr Sonal Kumar, discuss recent developments in treating primary biliary cholangitis (PBC) with new and emerging agents, as well as strategies to integrate these advances into clinical practice.Topics covered include: Methods of Assessing PBC Disease ProgressionNewer Agents for Second-line Treatment of PBCPrioritizing Symptom Management and Quality of Life With PBC TreatmentPresenters:Christopher L. Bowlus, MDLena Valenta Professor and ChiefDivision of Gastroenterology and HepatologySchool of Medicine University of California Davis Sacramento, CaliforniaSonal Kumar, MD, MPHAssistant Professor of MedicineDivision of Gastroenterology and HepatologyWeill Cornell Medical CollegeNew York, New YorkLink to full program: https://bit.ly/43nHx6UGet access to all of our new podcasts by subscribing to the CCO Medical Specialties Podcast on Apple Podcasts, Google Podcasts, or Spotify. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
Este domingo, o secretário-geral e o presidente do PS vão defender, na Comissão Nacional — órgão máximo entre congressos —, que o partido deve apoiar a candidatura presidencial do ex-líder António José Seguro. A decisão não é pacífica e o debate fica mais difícil ao saber-se que há um grupo de pessoas à direita, conotadas com o passismo, que consideram Seguro o melhor dos candidatos para assumir a chefia do Estado. Neste episódio, conversamos com a jornalista Rita Dinis.See omnystudio.com/listener for privacy information.
See all the Healthcasts at https://www.biobalancehealth.com/healthcast-blog WHAT YOU WILL LEARN: How to SCULPT YOUR MUSCLES AND TIGHTEN YOUR SKIN after weight loss! How to decrease VISCERAL FAT A new way to IMPROVE MUSCLE MASS by 30% for strength and beauty in 4 weeks DECREASE SUBCUTANEOUS FAT by 25% in 4 weekly treatments INCREASE MUSCLE DEFINITION with Emsculpt Neo A way to REHABILITATE AFTER SURGERY PRE-TREAT BEFORE SURGERY: Improve your post op joint surgery condition by increasing muscle around the joint HOW TO RECOVER Quickly AFTER CHILDBIRTH A Way to IMPROVE CORE AND PELVIC FLOOR STRENGTH How EM-Sculpt-Neo works Most of you know me as the expert in Bioidentical Hormone Pellet Replacement, but I am also expert in Skin and body care. If my patients have problems that your PCP has not been able to solve. I will refer you for new therapies, cutting edge treatments that work to treat your problem. The most common problem that my patients complain of is loss of muscle mass and changes in body fat that make them look old. I found a treatment that is not a laser, but the Emsculpt Neo uses safe and effective magnetic energy plus RF treatment to reduce fat and build muscle in a 30-minute painless treatment. Today I am going to talk about a painless treatment that we offer at my medical spa, BioBalance® Skin that has just been approved by the FDA for rehab after joint surgery. The magnetic energy (HIFEM) combined with RF energy increases muscle size and strength by 30%, dissolve fat by 25%, as well as tightens skin with the same treatment! EM Sculpt Neo is a 30-minute treatment that uses magnetic energy to make your muscles contract and is equal to thousands of crunches for 30 minutes. The RF portion breaks down subcutaneous fat in the same area. There is no work on your part, you just lie there, and your muscles respond to the magnetic pull by increasing in size and strength. Four sessions one week apart is the ideal number of treatments, and they come a in a package of four treatments to one area. The areas that most of us want to build muscle and lose fat in are our abs, upper arms, thighs, calves, love handles, and hips. If you need to do more than one area at a treatment you can do up to three areas, each for 30 minutes. If you have had joint surgery and need to increase your strength around that joint, EMSculpt Neo is very effective, after your doctor releases you to exercise. One of the big concerns with the new weight loss medications is that people often lose muscle as they lose weight. This is especially common after age 40, in those people who are not on testosterone pellets. EMSculpt Neo adds a tool that can preserve or even increase muscle mass and decrease fat where you want to lose it. EMSculpt Neo for fat loss and muscle building (not for rehabilitation) should be saved for those weight loss patients who lose enough weight to achieve a BMI under 30. For the best results, we suggest a high protein low carb diet, protein, low carb diet, to give your body the building blocks for muscle tissue. We also will suggest supplements for nutrition and to abstain from alcohol to get the best results. Healthy fat loss takes combination of EMSCULPT NEO, Weight Loss Medication, activity, Low carb high protein diet. We advise our patients over BMI of 30 to get started on weight loss first and continue diet medications while you are receiving EM-Sculpt Neo treatments. How do you lose weight without losing muscle? The Best Combination for the best results while you are losing weight on medication: EMSCULPT NEO to the areas you want to remove fat from Semaglutide or Tirzepatide medication to treat obesity for weight loss Testosterone Pellets if you are a woman over 40, and man over 50. Regular exercise like walking High protein diet Supplements to improve your ability to make muscle Who should do this EMSCULPT treatment? People who are working out but cannot do sit ups because of back injury Those folks who want fast muscle mass increase in specific areas Anyone who is on a weight loss program who is losing muscle and fat, or who has saggy skin in areas where they lost weight Patients anticipating a joint surgery Patients healing from joint surgery after PT Patients who cannot lift weights because of injury Those people who lift weights but cannot develop definition People with a Beer Belly with a lot of visceral fat Some people may not be able to enjoy this sculpting, muscle building method: We will do a free consultation before you sign up for a package of EMSculpt Neo and some patients will not get optimal results if they have any of the factors below: BMI greater than 30 Metal implants anywhere that are not titanium. Titanium is not magnetic, so it is ok to have a treatment if you have a titanium joint implant. No Rods or pins. Any pacemaker implant, pain pump under your skin, nerve stimulator or you are in the first 6 weeks post-surgery for any muscle area in the area. If you have a large abdominal hernia that was not repaired, then abdominal treatment is not advisable. You can still have other areas treated. If you have unrepaired joint damage, you can still have this treatment but let us know so we can slowly work the energy up around that joint. Those people who have a pannus, an apron of skin that hangs down below the vulva, or penis will not get enough relief from this procedure. These patients will need an abdominoplasty. This surgery is done by a plastic surgeon who removes excess skin and fat and repairs the muscles and fascia. You should not waste your money if you continue to drink alcohol while undergoing this treatment. Alcohol is a toxin and will prevent the growth of muscle and loss of body fat. Don't waste your money if you are not going to follow a low carb high protein diet during and after our treatment. How does EMSCULPT Work? EMSCULPT combines HIFEM (High Intensity Focused Electromagnetic technology) and RF (Radio Frequency). HIFEM uses magnetic energy to contract muscles in a particular area at intensities that are not achievable with routine weightlifting. Fat tissue in the treated area is also reduced by increasing metabolic activity. This results in Body Contouring. HIFEM is approved by the FDA for Body contouring, muscle stimulation, growth and to rehabilitate patients with injuries or after surgery. The second treatment that occurs at the same time as HIFEM is RF, Radio Frequency treatment. RF is a low frequency electromagnetic wave that heats up fat in 4 minutes to stimulate collagen and elastin to tighten skin. All this happens in 30 minutes with minimal discomfort. 4 treatments, one a month, is all that is needed to increase muscle 25% and to decrease fat by 30%, and to visibly improve skin tone. Answers to questions about this procedure: What should my diet consist of to optimize my treatment? To gain muscle you must eat your weight in pounds equivalent to grams of protein every day. E.g. If you weigh 200 lbs. and you want to gain muscle, you should eat 200 grams of protein a day. What foods should I eat to optimize my treatment? The best most concentrated protein is found in animal products-eggs, milk products, fish, chicken and red meat. What supplements will help support my treatment? You may want to supplement your diet with our BioBalance Magnesium combination twice a day, Probiotics, Creatine or Arginine and Ornithine combination. You should also take a methyl B12 and Methyl Folate while you are sculpting your body. Why can't I eat a lot of carbs and drink alcohol during or after the treatment? If you eat a high carb diet, your fat loss portion of Em-Sculpt will be limited, because whatever carb you eat over-stimulates insulin, which increases insulin resistance, and increases fat deposition. Whatever is eaten goes directly to fat again and replaces what you just lost. When can I start EMSculpt after joint surgery? After PT is completed or your surgeon releases you for exercise. Can I lift weights while I am being treated? Yes, but we advise not to lift weights the day before, the day of or the day after your EMSCULPT treatment. What does hydration have to be optimal for the treatment to work effectively? The human body is almost all water, and hydration is needed for muscle contraction. Muscles don't contract optimally when you are dehydrated. We put you on a body composition machine to both document your muscle mass and fat mass, as well as tell if you are hydrated adequately. Now that you know how EMSculpt Neo can change your body composition and build muscle, I hope you are comfortable enough to let us help you get the body you have always wanted. BioBalance Skin phone for an appointment:
Dan & Manny are joined by friend of the show, artist & pop culture enthusiast Andrew Breen to put the 1989 fantasy comedy horror film Little Monsters to the ultimate test—THE NOSTALGIA TEST! “Little Monsters is one of the most repellent, distasteful, truly creepy movies I've seen in a long time, a movie so unpleasant I can't really figure out why anybody wanted to make it, and I don't know why anybody would wanna see it.” -Roger Ebert It's officially Spooky Season and what better way to celebrate than to put one of the weirdest and creepiest movies ever made to the ultimate test. Little Monsters makes the plot of every David Lynch film look totally normal. This movie was suggested by the guest, Andrew Breen, who's an amazing artist and a pop culture nerd like Dan & Manny. Little Monsters looks like a club Bill Hader's SNL character Stefon would be partying at until everyone turns into a pile of clothes. This movie has everything, Fred Savage, Daniel Stern on the verge of murdering his whole family, the woman who owned The Cleveland Indians in Major League, and a monster named Snick, who's a cigarette cross from between the girl who turned into a blueberry before she died in Willy Wonka and a broke down Meatloaf. Not to mention a PCP riddled Howie Mandal as Maurice the monster, who is an eleven-year-old/200-year-old blue lunatic getting children grounded, yelled at, and probably hit (hey, it's the 80s). So set your monster catching traps, make your peanut butter and onion sandwiches, make sure to check the apple juice before you drink it, and come hangout as we see if Little Monsters passes The Nostalgia Test. Email us (thenostalgiatest@gmail.com) your thoughts, opinions, and topics for our next Nostalgia Test! Suggest A Test & Be Our Guest! We're always looking for a fun new topic for The Nostalgia Test. Hit the link above, tell us what you'd like to see tested, and be our guest for that episode! Andrew Breen is a Long Island local artist, his vibrant technicolor-drenched character illustrations immediately transport you back to yournostalgic latch-key kid Saturdays. From Horror icons to cult classics and deep cut 90s animated shows there's something for everyone to love. Check out his art & Follow: @Rocktapusjones_art Approximate Rundown 00:00 Introduction and Guest Introduction 00:39 Sponsor Shoutout and Guest's Art Background 01:53 Art Style and Inspirations 03:05 Favorite Art Pieces and Meet the Artist Night 03:36 Artistic Journey and Personal Insights 10:34 Transition to Movie Discussion 13:15 Little Monsters Movie Overview 15:33 Movie Analysis and Personal Reactions 19:11 Character and Plot Deep Dive 36:34 Maurice's Performance and Movie Trivia 48:03 Noise and Chaos in the Movie 48:28 Parental Reactions and Monster Logic 49:54 Brian's Actions and Parental Absence 52:12 Monster World Rules and Anarchy 55:38 Design and Production Insights 59:15 The Final Battle and Plot Holes 01:07:26 Maurice's Character and Ending 01:19:01 Nostalgia Test and Final Thoughts Book The Nostalgia Test Podcast Bring The Nostalgia Test Podcast's high energy fun and comedy on your podcast, to host your themed parties & special events! The Nostalgia Test Podcast will create an unforgettable Nostalgic experience for any occasion because we are the party! We bring it 100% of the time! Email us at thenostalgiatest@gmail.com or fill out the form at this link. LET'S GET NOSTALGIC! Keep up with all things The Nostalgia Test Podcast on Instagram | Substack | Discord | TikTok | Bluesky | YouTube | Facebook The intro and outro music ('Neon Attack 80s') is by Emanmusic. The Lithology Brewing ad music ("Red, White, Black, & Blue") is by PEG and the Rejected
Operação Míscaros: o plano montado em segredo por um comandante da Força Aérea para desviar aviões e reagir ao 25 de novembro, levando ao recuo de Álvaro Cunhal. A descoordenação com os comandos de Jaime Neves no ataque à Polícia Militar. E a desilusão com o ex-ministro do Trabalho que o PCP enviou para Cuba e Angola. Parte II da entrevista ao General Vaz Afonso: “O PCP esteve muito próximo de sair vitorioso, mas nunca mereceu as palavras de Melo Antunes. Nunca foi democrático.”See omnystudio.com/listener for privacy information.
Vasco Lourenço pede união à esquerda em torno de Seguro e critica candidatura de João Ferreira em Lisboa. É justo ónus estar no PCP e no BE? A flotilha serve só carreiras? E os caças de Nuno MeloSee omnystudio.com/listener for privacy information.
O Parlamento aprovou as alterações à Lei de Estrangeiros, com os votos da direita. PS, Livre, PCP, BE e PAN votaram contra. O editor de Política do Observador, Rui Pedro Antunes, é o convidado.See omnystudio.com/listener for privacy information.
On the latest episode of the podcast, Doug wonders if Angel Dust and PCP just don't exist anymore or if they just have new names, Jamie refers to the hero as 'Seed Star' for reasons that she feels are obvious, and we both realize that neither of us would last more than a day or two in the future hellish world that this movie posits (Doug refuses to live in a sewer and Jamie would attempt to bargain with the Terminators). Don't waste perfectly good ice cream playing pranks on a waitress, appreciate things like trees and grass while they're still here, and join us as we constantly get distracted by the little things while we discuss, The Terminator!The Terminator is a 1984 film written and directed by James Cameron and starring Arnold Schwarzenegger, Linda Hamilton, Michael Biehn, Paul Winfield, Lance Henriksen, Rick Rossovich, Bess Motta, Earl Boen, Bill Paxton & Dick Miller.Visit our YouTube ChannelMerch on TeePublic Follow us on TwitterFollow on InstagramFind us on FacebookDoug's Schitt's Creek podcast, Schitt's & Giggles can be found here: https://podcasts.apple.com/us/podcast/schitts-and-giggles-a-schitts-creek-podcast/id1490637008
Welcome back! We are excited to share a new episode, and a revised format. Ever think there might be a connection between nicknames and a commonly-used term in health care? Listen, and find out! This month, Dr Thomas White addresses the term "PCP" - its history, its positive and negative connotations, and (spoiler alert!) why he wishes the term would go away. He interviews two of our popular guests from previous episodes - Dr Shauna Guthrie of Henderson NC and Dr Tommy Newton of Clinton NC - to get their wise perspectives. We hope you find this discussion interesting and thought-provoking. Thank you for your support! And please visit our website, The Family Doctor Podcast. Dr. Lee Beatty's blog has some more thoughts about PCP.
Somebody Save Me: The Official, but mostly Unofficial, Smallville Podcast
Smallville Presents: Crimson, Pt. II and Zod's 9/11It's Valentine's Day and Lois refuses to do anything romantic with Clark, but he isn't helping either. After a blast of fairy dust, a.k.a. PCP, laced with Gemstone Kryptonite, Clark now has the ability to "persuade" the people he talks to. Lois becomes a traditional housewife. Chloe somehow gets worse and is a psychotic C.K. bodyguard. Even Clark persuades himself to try and kill Tess after Zod tells him she killed the clone of Jor-El (#9.7)... or did she?
© 2020-2025 Ivy Podcast Discovery LLC
